Motif 1043 (n=111)
Position-wise Probabilities
Download
uniprot | genes | site | source | protein | function |
---|---|---|---|---|---|
A6H8Y1 | BDP1 | S2044 | ochoa | Transcription factor TFIIIB component B'' homolog (Transcription factor IIIB 150) (TFIIIB150) (Transcription factor-like nuclear regulator) | General activator of RNA polymerase III transcription. Requires for transcription from all three types of polymerase III promoters. Requires for transcription of genes with internal promoter elements and with promoter elements upstream of the initiation site. {ECO:0000269|PubMed:11040218}. |
A6NKT7 | RGPD3 | T1475 | ochoa | RanBP2-like and GRIP domain-containing protein 3 | None |
E9PAV3 | NACA | S1977 | ochoa | Nascent polypeptide-associated complex subunit alpha, muscle-specific form (Alpha-NAC, muscle-specific form) (skNAC) | Cardiac- and muscle-specific transcription factor. May act to regulate the expression of genes involved in the development of myotubes. Plays a critical role in ventricular cardiomyocyte expansion and regulates postnatal skeletal muscle growth and regeneration. Involved in the organized assembly of thick and thin filaments of myofibril sarcomeres (By similarity). {ECO:0000250|UniProtKB:P70670}. |
E9PMD0 | None | S240 | ochoa | Uncharacterized protein | None |
I3L0D1 | RBAK-RBAKDN | S78 | ochoa | HCG1647537, isoform CRA_b (RBAK-RBAKDN readthrough) | None |
M0QX08 | None | S58 | ochoa | Protein kinase domain-containing protein | None |
O00562 | PITPNM1 | S896 | ochoa|psp | Membrane-associated phosphatidylinositol transfer protein 1 (Drosophila retinal degeneration B homolog) (Phosphatidylinositol transfer protein, membrane-associated 1) (PITPnm 1) (Pyk2 N-terminal domain-interacting receptor 2) (NIR-2) | Catalyzes the transfer of phosphatidylinositol (PI) between membranes (PubMed:10531358, PubMed:22822086). Binds PI, phosphatidylcholine (PC) and phosphatidic acid (PA) with the binding affinity order of PI > PA > PC (PubMed:22822086). Regulates RHOA activity, and plays a role in cytoskeleton remodeling (PubMed:11909959). Necessary for normal completion of cytokinesis (PubMed:15125835). Plays a role in maintaining normal diacylglycerol levels in the Golgi apparatus (PubMed:15723057). Necessary for maintaining the normal structure of the endoplasmic reticulum and the Golgi apparatus (PubMed:15545272). Required for protein export from the endoplasmic reticulum and the Golgi (PubMed:15723057). Binds calcium ions (PubMed:10022914). {ECO:0000269|PubMed:10022914, ECO:0000269|PubMed:10531358, ECO:0000269|PubMed:11909959, ECO:0000269|PubMed:15545272, ECO:0000269|PubMed:15723057, ECO:0000269|PubMed:22822086}. |
O14715 | RGPD8 | T1474 | ochoa | RANBP2-like and GRIP domain-containing protein 8 (Ran-binding protein 2-like 3) (RanBP2-like 3) (RanBP2L3) | None |
O15061 | SYNM | S777 | ochoa | Synemin (Desmuslin) | Type-VI intermediate filament (IF) which plays an important cytoskeletal role within the muscle cell cytoskeleton. It forms heteromeric IFs with desmin and/or vimentin, and via its interaction with cytoskeletal proteins alpha-dystrobrevin, dystrophin, talin-1, utrophin and vinculin, is able to link these heteromeric IFs to adherens-type junctions, such as to the costameres, neuromuscular junctions, and myotendinous junctions within striated muscle cells. {ECO:0000269|PubMed:11353857, ECO:0000269|PubMed:16777071, ECO:0000269|PubMed:18028034}. |
O43491 | EPB41L2 | S598 | ochoa | Band 4.1-like protein 2 (Erythrocyte membrane protein band 4.1-like 2) (Generally expressed protein 4.1) (4.1G) | Required for dynein-dynactin complex and NUMA1 recruitment at the mitotic cell cortex during anaphase (PubMed:23870127). {ECO:0000269|PubMed:23870127}. |
O60291 | MGRN1 | S506 | ochoa | E3 ubiquitin-protein ligase MGRN1 (EC 2.3.2.27) (Mahogunin RING finger protein 1) (RING finger protein 156) (RING-type E3 ubiquitin transferase MGRN1) | E3 ubiquitin-protein ligase. Mediates monoubiquitination at multiple sites of TSG101 in the presence of UBE2D1, but not of UBE2G1, nor UBE2H. Plays a role in the regulation of endosome-to-lysosome trafficking. Impairs MC1R- and MC4R-signaling by competing with GNAS-binding to MCRs and inhibiting agonist-induced cAMP production. Does not inhibit ADRB2-signaling. Does not promote MC1R ubiquitination. Acts also as a negative regulator of hedgehog signaling (By similarity). {ECO:0000250|UniProtKB:Q9D074, ECO:0000269|PubMed:17229889, ECO:0000269|PubMed:19703557, ECO:0000269|PubMed:19737927}. |
O60292 | SIPA1L3 | S326 | ochoa | Signal-induced proliferation-associated 1-like protein 3 (SIPA1-like protein 3) (SPA-1-like protein 3) | Plays a critical role in epithelial cell morphogenesis, polarity, adhesion and cytoskeletal organization in the lens (PubMed:26231217). {ECO:0000269|PubMed:26231217}. |
O60292 | SIPA1L3 | S1534 | ochoa | Signal-induced proliferation-associated 1-like protein 3 (SIPA1-like protein 3) (SPA-1-like protein 3) | Plays a critical role in epithelial cell morphogenesis, polarity, adhesion and cytoskeletal organization in the lens (PubMed:26231217). {ECO:0000269|PubMed:26231217}. |
O75376 | NCOR1 | S992 | ochoa | Nuclear receptor corepressor 1 (N-CoR) (N-CoR1) | Mediates transcriptional repression by certain nuclear receptors (PubMed:20812024). Part of a complex which promotes histone deacetylation and the formation of repressive chromatin structures which may impede the access of basal transcription factors. Participates in the transcriptional repressor activity produced by BCL6. Recruited by ZBTB7A to the androgen response elements/ARE on target genes, negatively regulates androgen receptor signaling and androgen-induced cell proliferation (PubMed:20812024). Mediates the NR1D1-dependent repression and circadian regulation of TSHB expression (By similarity). The NCOR1-HDAC3 complex regulates the circadian expression of the core clock gene ARTNL/BMAL1 and the genes involved in lipid metabolism in the liver (By similarity). {ECO:0000250|UniProtKB:Q60974, ECO:0000269|PubMed:14527417, ECO:0000269|PubMed:20812024}. |
O94804 | STK10 | S438 | ochoa | Serine/threonine-protein kinase 10 (EC 2.7.11.1) (Lymphocyte-oriented kinase) | Serine/threonine-protein kinase involved in regulation of lymphocyte migration. Phosphorylates MSN, and possibly PLK1. Involved in regulation of lymphocyte migration by mediating phosphorylation of ERM proteins such as MSN. Acts as a negative regulator of MAP3K1/MEKK1. May also act as a cell cycle regulator by acting as a polo kinase kinase: mediates phosphorylation of PLK1 in vitro; however such data require additional evidences in vivo. {ECO:0000269|PubMed:11903060, ECO:0000269|PubMed:12639966, ECO:0000269|PubMed:19255442}. |
O96019 | ACTL6A | S86 | ochoa|psp | Actin-like protein 6A (53 kDa BRG1-associated factor A) (Actin-related protein Baf53a) (ArpNbeta) (BRG1-associated factor 53A) (BAF53A) (INO80 complex subunit K) | Involved in transcriptional activation and repression of select genes by chromatin remodeling (alteration of DNA-nucleosome topology). Component of SWI/SNF chromatin remodeling complexes that carry out key enzymatic activities, changing chromatin structure by altering DNA-histone contacts within a nucleosome in an ATP-dependent manner. Required for maximal ATPase activity of SMARCA4/BRG1/BAF190A and for association of the SMARCA4/BRG1/BAF190A containing remodeling complex BAF with chromatin/nuclear matrix. Belongs to the neural progenitors-specific chromatin remodeling complex (npBAF complex) and is required for the proliferation of neural progenitors. During neural development a switch from a stem/progenitor to a postmitotic chromatin remodeling mechanism occurs as neurons exit the cell cycle and become committed to their adult state. The transition from proliferating neural stem/progenitor cells to postmitotic neurons requires a switch in subunit composition of the npBAF and nBAF complexes. As neural progenitors exit mitosis and differentiate into neurons, npBAF complexes which contain ACTL6A/BAF53A and PHF10/BAF45A, are exchanged for homologous alternative ACTL6B/BAF53B and DPF1/BAF45B or DPF3/BAF45C subunits in neuron-specific complexes (nBAF). The npBAF complex is essential for the self-renewal/proliferative capacity of the multipotent neural stem cells. The nBAF complex along with CREST plays a role regulating the activity of genes essential for dendrite growth (By similarity). Component of the NuA4 histone acetyltransferase (HAT) complex which is involved in transcriptional activation of select genes principally by acetylation of nucleosomal histones H4 and H2A. This modification may both alter nucleosome - DNA interactions and promote interaction of the modified histones with other proteins which positively regulate transcription. This complex may be required for the activation of transcriptional programs associated with oncogene and proto-oncogene mediated growth induction, tumor suppressor mediated growth arrest and replicative senescence, apoptosis, and DNA repair. NuA4 may also play a direct role in DNA repair when recruited to sites of DNA damage. Putative core component of the chromatin remodeling INO80 complex which is involved in transcriptional regulation, DNA replication and probably DNA repair. {ECO:0000250|UniProtKB:Q9Z2N8, ECO:0000269|PubMed:14966270, ECO:0000269|PubMed:29374058, ECO:0000303|PubMed:15196461, ECO:0000303|PubMed:22952240, ECO:0000303|PubMed:26601204}. |
O96020 | CCNE2 | S67 | ochoa | G1/S-specific cyclin-E2 | Essential for the control of the cell cycle at the late G1 and early S phase. {ECO:0000269|PubMed:9840927, ECO:0000269|PubMed:9840943, ECO:0000269|PubMed:9858585}. |
P05455 | SSB | S92 | ochoa | Lupus La protein (La autoantigen) (La ribonucleoprotein) (Sjoegren syndrome type B antigen) (SS-B) | Binds to the 3' poly(U) terminus of nascent RNA polymerase III transcripts, protecting them from exonuclease digestion and facilitating their folding and maturation (PubMed:2470590, PubMed:3192525). In case of Coxsackievirus B3 infection, binds to the viral internal ribosome entry site (IRES) and stimulates the IRES-mediated translation (PubMed:12384597). {ECO:0000269|PubMed:12384597, ECO:0000269|PubMed:2470590, ECO:0000269|PubMed:3192525}. |
P0DJD0 | RGPD1 | T1459 | ochoa | RANBP2-like and GRIP domain-containing protein 1 (Ran-binding protein 2-like 6) (RanBP2-like 6) (RanBP2L6) | None |
P0DJD1 | RGPD2 | T1467 | ochoa | RANBP2-like and GRIP domain-containing protein 2 (Ran-binding protein 2-like 2) (RanBP2-like 2) (RanBP2L2) | None |
P16157 | ANK1 | S856 | ochoa | Ankyrin-1 (ANK-1) (Ankyrin-R) (Erythrocyte ankyrin) | Component of the ankyrin-1 complex, a multiprotein complex involved in the stability and shape of the erythrocyte membrane (PubMed:35835865). Attaches integral membrane proteins to cytoskeletal elements; binds to the erythrocyte membrane protein band 4.2, to Na-K ATPase, to the lymphocyte membrane protein GP85, and to the cytoskeletal proteins fodrin, tubulin, vimentin and desmin. Erythrocyte ankyrins also link spectrin (beta chain) to the cytoplasmic domain of the erythrocytes anion exchange protein; they retain most or all of these binding functions. {ECO:0000269|PubMed:12456646, ECO:0000269|PubMed:35835865}.; FUNCTION: [Isoform Mu17]: Together with obscurin in skeletal muscle may provide a molecular link between the sarcoplasmic reticulum and myofibrils. {ECO:0000269|PubMed:12527750}. |
P21283 | ATP6V1C1 | S269 | ochoa | V-type proton ATPase subunit C 1 (V-ATPase subunit C 1) (Vacuolar proton pump subunit C 1) | Subunit of the V1 complex of vacuolar(H+)-ATPase (V-ATPase), a multisubunit enzyme composed of a peripheral complex (V1) that hydrolyzes ATP and a membrane integral complex (V0) that translocates protons (PubMed:33065002). V-ATPase is responsible for acidifying and maintaining the pH of intracellular compartments and in some cell types, is targeted to the plasma membrane, where it is responsible for acidifying the extracellular environment (By similarity). Subunit C is necessary for the assembly of the catalytic sector of the enzyme and is likely to have a specific function in its catalytic activity (By similarity). {ECO:0000250|UniProtKB:P21282, ECO:0000250|UniProtKB:P31412, ECO:0000269|PubMed:33065002}. |
P30876 | POLR2B | S106 | ochoa | DNA-directed RNA polymerase II subunit RPB2 (EC 2.7.7.6) (3'-5' exoribonuclease) (EC 3.1.13.-) (DNA-directed RNA polymerase II 140 kDa polypeptide) (DNA-directed RNA polymerase II subunit B) (RNA polymerase II subunit 2) (RNA polymerase II subunit B2) (RNA-directed RNA polymerase II subunit RPB2) (EC 2.7.7.48) | Catalytic core component of RNA polymerase II (Pol II), a DNA-dependent RNA polymerase which synthesizes mRNA precursors and many functional non-coding RNAs using the four ribonucleoside triphosphates as substrates (By similarity) (PubMed:27193682, PubMed:30190596, PubMed:9852112). Pol II-mediated transcription cycle proceeds through transcription initiation, transcription elongation and transcription termination stages. During transcription initiation, Pol II pre-initiation complex (PIC) is recruited to DNA promoters, with focused-type promoters containing either the initiator (Inr) element, or the TATA-box found in cell-type specific genes and dispersed-type promoters that often contain hypomethylated CpG islands usually found in housekeeping genes. Once the polymerase has escaped from the promoter it enters the elongation phase during which RNA is actively polymerized, based on complementarity with the template DNA strand. Transcription termination involves the release of the RNA transcript and polymerase from the DNA (PubMed:27193682, PubMed:30190596, PubMed:9852112). Forms Pol II active center together with the largest subunit POLR2A/RPB1. Appends one nucleotide at a time to the 3' end of the nascent RNA, with POLR2A/RPB1 most likely contributing a Mg(2+)-coordinating DxDGD motif and POLR2B/RPB2 participating in the coordination of a second Mg(2+) ion and providing lysine residues believed to facilitate Watson-Crick base pairing between the incoming nucleotide and template base. Typically, Mg(2+) ions direct a 5' nucleoside triphosphate to form a phosphodiester bond with the 3' hydroxyl of the preceding nucleotide of the nascent RNA, with the elimination of pyrophosphate. The reversible pyrophosphorolysis can occur at high pyrophosphate concentrations (By similarity) (PubMed:30190596, PubMed:9852112). Can proofread the nascent RNA transcript by means of a 3' -> 5' exonuclease activity. If a ribonucleotide is mis-incorporated, backtracks along the template DNA and cleaves the phosphodiester bond releasing the mis-incorporated 5'-ribonucleotide (By similarity) (PubMed:8381534). {ECO:0000250|UniProtKB:A5PJW8, ECO:0000269|PubMed:27193682, ECO:0000269|PubMed:30190596, ECO:0000269|PubMed:8381534, ECO:0000269|PubMed:9852112}.; FUNCTION: RNA-dependent RNA polymerase that catalyzes the extension of a non-coding RNA (ncRNA) at the 3'-end using the four ribonucleoside triphosphates as substrates. An internal ncRNA sequence near the 3'-end serves as a template in a single-round Pol II-mediated RNA polymerization reaction. May decrease the stability of ncRNAs that repress Pol II-mediated gene transcription. {ECO:0000269|PubMed:23395899}. |
P36404 | ARL2 | S45 | ochoa | ADP-ribosylation factor-like protein 2 | Small GTP-binding protein which cycles between an inactive GDP-bound and an active GTP-bound form, and the rate of cycling is regulated by guanine nucleotide exchange factors (GEF) and GTPase-activating proteins (GAP). GTP-binding protein that does not act as an allosteric activator of the cholera toxin catalytic subunit. Regulates formation of new microtubules and centrosome integrity. Prevents the TBCD-induced microtubule destruction. Participates in association with TBCD, in the disassembly of the apical junction complexes. Antagonizes the effect of TBCD on epithelial cell detachment and tight and adherens junctions disassembly. Together with ARL2, plays a role in the nuclear translocation, retention and transcriptional activity of STAT3. Component of a regulated secretory pathway involved in Ca(2+)-dependent release of acetylcholine. Required for normal progress through the cell cycle (PubMed:10831612, PubMed:16525022, PubMed:18234692, PubMed:18588884, PubMed:20740604). Also regulates mitochondrial integrity and function (PubMed:30945270). {ECO:0000269|PubMed:10831612, ECO:0000269|PubMed:16525022, ECO:0000269|PubMed:18234692, ECO:0000269|PubMed:18588884, ECO:0000269|PubMed:20740604, ECO:0000269|PubMed:30945270}. |
P38432 | COIL | S489 | ochoa|psp | Coilin (p80-coilin) | Component of nuclear coiled bodies, also known as Cajal bodies or CBs, which are involved in the modification and assembly of nucleoplasmic snRNPs. {ECO:0000269|PubMed:7679389}. |
P41236 | PPP1R2 | S130 | ochoa | Protein phosphatase inhibitor 2 (IPP-2) | Inhibitor of protein-phosphatase 1. |
P42566 | EPS15 | S563 | ochoa | Epidermal growth factor receptor substrate 15 (Protein Eps15) (Protein AF-1p) | Involved in cell growth regulation. May be involved in the regulation of mitogenic signals and control of cell proliferation. Involved in the internalization of ligand-inducible receptors of the receptor tyrosine kinase (RTK) type, in particular EGFR. Plays a role in the assembly of clathrin-coated pits (CCPs). Acts as a clathrin adapter required for post-Golgi trafficking. Seems to be involved in CCPs maturation including invagination or budding. Involved in endocytosis of integrin beta-1 (ITGB1) and transferrin receptor (TFR); internalization of ITGB1 as DAB2-dependent cargo but not TFR seems to require association with DAB2. {ECO:0000269|PubMed:16903783, ECO:0000269|PubMed:18362181, ECO:0000269|PubMed:19458185, ECO:0000269|PubMed:22648170}. |
P46100 | ATRX | S656 | ochoa | Transcriptional regulator ATRX (EC 3.6.4.12) (ATP-dependent helicase ATRX) (X-linked helicase II) (X-linked nuclear protein) (XNP) (Znf-HX) | Involved in transcriptional regulation and chromatin remodeling. Facilitates DNA replication in multiple cellular environments and is required for efficient replication of a subset of genomic loci. Binds to DNA tandem repeat sequences in both telomeres and euchromatin and in vitro binds DNA quadruplex structures. May help stabilizing G-rich regions into regular chromatin structures by remodeling G4 DNA and incorporating H3.3-containing nucleosomes. Catalytic component of the chromatin remodeling complex ATRX:DAXX which has ATP-dependent DNA translocase activity and catalyzes the replication-independent deposition of histone H3.3 in pericentric DNA repeats outside S-phase and telomeres, and the in vitro remodeling of H3.3-containing nucleosomes. Its heterochromatin targeting is proposed to involve a combinatorial readout of histone H3 modifications (specifically methylation states of H3K9 and H3K4) and association with CBX5. Involved in maintaining telomere structural integrity in embryonic stem cells which probably implies recruitment of CBX5 to telomeres. Reports on the involvement in transcriptional regulation of telomeric repeat-containing RNA (TERRA) are conflicting; according to a report, it is not sufficient to decrease chromatin condensation at telomeres nor to increase expression of telomeric RNA in fibroblasts (PubMed:24500201). May be involved in telomere maintenance via recombination in ALT (alternative lengthening of telomeres) cell lines. Acts as a negative regulator of chromatin incorporation of transcriptionally repressive histone MACROH2A1, particularily at telomeres and the alpha-globin cluster in erythroleukemic cells. Participates in the allele-specific gene expression at the imprinted IGF2/H19 gene locus. On the maternal allele, required for the chromatin occupancy of SMC1 and CTCTF within the H19 imprinting control region (ICR) and involved in esatblishment of histone tails modifications in the ICR. May be involved in brain development and facial morphogenesis. Binds to zinc-finger coding genes with atypical chromatin signatures and regulates its H3K9me3 levels. Forms a complex with ZNF274, TRIM28 and SETDB1 to facilitate the deposition and maintenance of H3K9me3 at the 3' exons of zinc-finger genes (PubMed:27029610). {ECO:0000269|PubMed:12953102, ECO:0000269|PubMed:14990586, ECO:0000269|PubMed:20504901, ECO:0000269|PubMed:20651253, ECO:0000269|PubMed:21029860, ECO:0000269|PubMed:22391447, ECO:0000269|PubMed:22829774, ECO:0000269|PubMed:24500201, ECO:0000269|PubMed:27029610}. |
P49792 | RANBP2 | T2450 | ochoa | E3 SUMO-protein ligase RanBP2 (EC 2.3.2.-) (358 kDa nucleoporin) (Nuclear pore complex protein Nup358) (Nucleoporin Nup358) (Ran-binding protein 2) (RanBP2) (p270) | E3 SUMO-protein ligase which facilitates SUMO1 and SUMO2 conjugation by UBE2I (PubMed:11792325, PubMed:12032081, PubMed:15378033, PubMed:15931224, PubMed:22194619). Involved in transport factor (Ran-GTP, karyopherin)-mediated protein import via the F-G repeat-containing domain which acts as a docking site for substrates (PubMed:7775481). Binds single-stranded RNA (in vitro) (PubMed:7775481). May bind DNA (PubMed:7775481). Component of the nuclear export pathway (PubMed:10078529). Specific docking site for the nuclear export factor exportin-1 (PubMed:10078529). Inhibits EIF4E-dependent mRNA export (PubMed:22902403). Sumoylates PML at 'Lys-490' which is essential for the proper assembly of PML-NB (PubMed:22155184). Recruits BICD2 to the nuclear envelope and cytoplasmic stacks of nuclear pore complex known as annulate lamellae during G2 phase of cell cycle (PubMed:20386726). Probable inactive PPIase with no peptidyl-prolyl cis-trans isomerase activity (PubMed:20676357, PubMed:23353830). {ECO:0000269|PubMed:11792325, ECO:0000269|PubMed:12032081, ECO:0000269|PubMed:15378033, ECO:0000269|PubMed:15931224, ECO:0000269|PubMed:20386726, ECO:0000269|PubMed:20676357, ECO:0000269|PubMed:22155184, ECO:0000269|PubMed:22194619, ECO:0000269|PubMed:22902403, ECO:0000269|PubMed:23353830, ECO:0000269|PubMed:7775481, ECO:0000303|PubMed:10078529}. |
P51398 | DAP3 | S220 | psp | Small ribosomal subunit protein mS29 (EC 3.6.5.-) (28S ribosomal protein S29, mitochondrial) (MRP-S29) (S29mt) (Death-associated protein 3) (DAP-3) (Ionizing radiation resistance conferring protein) | As a component of the mitochondrial small ribosomal subunit, it plays a role in the translation of mitochondrial mRNAs (PubMed:39701103). Involved in mediating interferon-gamma-induced cell death (PubMed:7499268). Displays GTPase activity in vitro (PubMed:39701103). {ECO:0000269|PubMed:39701103, ECO:0000269|PubMed:7499268}. |
P51587 | BRCA2 | S2095 | ochoa | Breast cancer type 2 susceptibility protein (Fanconi anemia group D1 protein) | Involved in double-strand break repair and/or homologous recombination. Binds RAD51 and potentiates recombinational DNA repair by promoting assembly of RAD51 onto single-stranded DNA (ssDNA). Acts by targeting RAD51 to ssDNA over double-stranded DNA, enabling RAD51 to displace replication protein-A (RPA) from ssDNA and stabilizing RAD51-ssDNA filaments by blocking ATP hydrolysis. Part of a PALB2-scaffolded HR complex containing RAD51C and which is thought to play a role in DNA repair by HR. May participate in S phase checkpoint activation. Binds selectively to ssDNA, and to ssDNA in tailed duplexes and replication fork structures. May play a role in the extension step after strand invasion at replication-dependent DNA double-strand breaks; together with PALB2 is involved in both POLH localization at collapsed replication forks and DNA polymerization activity. In concert with NPM1, regulates centrosome duplication. Interacts with the TREX-2 complex (transcription and export complex 2) subunits PCID2 and SEM1, and is required to prevent R-loop-associated DNA damage and thus transcription-associated genomic instability. Silencing of BRCA2 promotes R-loop accumulation at actively transcribed genes in replicating and non-replicating cells, suggesting that BRCA2 mediates the control of R-loop associated genomic instability, independently of its known role in homologous recombination (PubMed:24896180). {ECO:0000269|PubMed:15115758, ECO:0000269|PubMed:15199141, ECO:0000269|PubMed:15671039, ECO:0000269|PubMed:18317453, ECO:0000269|PubMed:20729832, ECO:0000269|PubMed:20729858, ECO:0000269|PubMed:20729859, ECO:0000269|PubMed:21084279, ECO:0000269|PubMed:21719596, ECO:0000269|PubMed:24485656, ECO:0000269|PubMed:24896180}. |
P54727 | RAD23B | S160 | ochoa | UV excision repair protein RAD23 homolog B (HR23B) (hHR23B) (XP-C repair-complementing complex 58 kDa protein) (p58) | Multiubiquitin chain receptor involved in modulation of proteasomal degradation. Binds to polyubiquitin chains. Proposed to be capable to bind simultaneously to the 26S proteasome and to polyubiquitinated substrates and to deliver ubiquitinated proteins to the proteasome. May play a role in endoplasmic reticulum-associated degradation (ERAD) of misfolded glycoproteins by association with PNGase and delivering deglycosylated proteins to the proteasome.; FUNCTION: Involved in global genome nucleotide excision repair (GG-NER) by acting as component of the XPC complex. Cooperatively with CETN2 appears to stabilize XPC. May protect XPC from proteasomal degradation.; FUNCTION: The XPC complex is proposed to represent the first factor bound at the sites of DNA damage and together with other core recognition factors, XPA, RPA and the TFIIH complex, is part of the pre-incision (or initial recognition) complex. The XPC complex recognizes a wide spectrum of damaged DNA characterized by distortions of the DNA helix such as single-stranded loops, mismatched bubbles or single-stranded overhangs. The orientation of XPC complex binding appears to be crucial for inducing a productive NER. XPC complex is proposed to recognize and to interact with unpaired bases on the undamaged DNA strand which is followed by recruitment of the TFIIH complex and subsequent scanning for lesions in the opposite strand in a 5'-to-3' direction by the NER machinery. Cyclobutane pyrimidine dimers (CPDs) which are formed upon UV-induced DNA damage esacpe detection by the XPC complex due to a low degree of structural perurbation. Instead they are detected by the UV-DDB complex which in turn recruits and cooperates with the XPC complex in the respective DNA repair. In vitro, the XPC:RAD23B dimer is sufficient to initiate NER; it preferentially binds to cisplatin and UV-damaged double-stranded DNA and also binds to a variety of chemically and structurally diverse DNA adducts. XPC:RAD23B contacts DNA both 5' and 3' of a cisplatin lesion with a preference for the 5' side. XPC:RAD23B induces a bend in DNA upon binding. XPC:RAD23B stimulates the activity of DNA glycosylases TDG and SMUG1. |
P78527 | PRKDC | S1203 | ochoa | DNA-dependent protein kinase catalytic subunit (DNA-PK catalytic subunit) (DNA-PKcs) (EC 2.7.11.1) (DNPK1) (Ser-473 kinase) (S473K) (p460) | Serine/threonine-protein kinase that acts as a molecular sensor for DNA damage (PubMed:11955432, PubMed:12649176, PubMed:14734805, PubMed:33854234). Involved in DNA non-homologous end joining (NHEJ) required for double-strand break (DSB) repair and V(D)J recombination (PubMed:11955432, PubMed:12649176, PubMed:14734805, PubMed:33854234, PubMed:34352203). Must be bound to DNA to express its catalytic properties (PubMed:11955432). Promotes processing of hairpin DNA structures in V(D)J recombination by activation of the hairpin endonuclease artemis (DCLRE1C) (PubMed:11955432). Recruited by XRCC5 and XRCC6 to DNA ends and is required to (1) protect and align broken ends of DNA, thereby preventing their degradation, (2) and sequester the DSB for repair by NHEJ (PubMed:11955432, PubMed:12649176, PubMed:14734805, PubMed:15574326, PubMed:33854234). Acts as a scaffold protein to aid the localization of DNA repair proteins to the site of damage (PubMed:11955432, PubMed:12649176, PubMed:14734805, PubMed:15574326). The assembly of the DNA-PK complex at DNA ends is also required for the NHEJ ligation step (PubMed:11955432, PubMed:12649176, PubMed:14734805, PubMed:15574326). Found at the ends of chromosomes, suggesting a further role in the maintenance of telomeric stability and the prevention of chromosomal end fusion (By similarity). Also involved in modulation of transcription (PubMed:11955432, PubMed:12649176, PubMed:14734805, PubMed:15574326). As part of the DNA-PK complex, involved in the early steps of ribosome assembly by promoting the processing of precursor rRNA into mature 18S rRNA in the small-subunit processome (PubMed:32103174). Binding to U3 small nucleolar RNA, recruits PRKDC and XRCC5/Ku86 to the small-subunit processome (PubMed:32103174). Recognizes the substrate consensus sequence [ST]-Q (PubMed:11955432, PubMed:12649176, PubMed:14734805, PubMed:15574326). Phosphorylates 'Ser-139' of histone variant H2AX, thereby regulating DNA damage response mechanism (PubMed:14627815, PubMed:16046194). Phosphorylates ASF1A, DCLRE1C, c-Abl/ABL1, histone H1, HSPCA, c-jun/JUN, p53/TP53, PARP1, POU2F1, DHX9, FH, SRF, NHEJ1/XLF, XRCC1, XRCC4, XRCC5, XRCC6, WRN, MYC and RFA2 (PubMed:10026262, PubMed:10467406, PubMed:11889123, PubMed:12509254, PubMed:14599745, PubMed:14612514, PubMed:14704337, PubMed:15177042, PubMed:1597196, PubMed:16397295, PubMed:18644470, PubMed:2247066, PubMed:2507541, PubMed:26237645, PubMed:26666690, PubMed:28712728, PubMed:29478807, PubMed:30247612, PubMed:8407951, PubMed:8464713, PubMed:9139719, PubMed:9362500). Can phosphorylate C1D not only in the presence of linear DNA but also in the presence of supercoiled DNA (PubMed:9679063). Ability to phosphorylate p53/TP53 in the presence of supercoiled DNA is dependent on C1D (PubMed:9363941). Acts as a regulator of the phosphatidylinositol 3-kinase/protein kinase B signal transduction by mediating phosphorylation of 'Ser-473' of protein kinase B (PKB/AKT1, PKB/AKT2, PKB/AKT3), promoting their activation (PubMed:15262962). Contributes to the determination of the circadian period length by antagonizing phosphorylation of CRY1 'Ser-588' and increasing CRY1 protein stability, most likely through an indirect mechanism (By similarity). Plays a role in the regulation of DNA virus-mediated innate immune response by assembling into the HDP-RNP complex, a complex that serves as a platform for IRF3 phosphorylation and subsequent innate immune response activation through the cGAS-STING pathway (PubMed:28712728). Also regulates the cGAS-STING pathway by catalyzing phosphorylation of CGAS, thereby impairing CGAS oligomerization and activation (PubMed:33273464). Also regulates the cGAS-STING pathway by mediating phosphorylation of PARP1 (PubMed:35460603). {ECO:0000250|UniProtKB:P97313, ECO:0000269|PubMed:10026262, ECO:0000269|PubMed:10467406, ECO:0000269|PubMed:11889123, ECO:0000269|PubMed:11955432, ECO:0000269|PubMed:12509254, ECO:0000269|PubMed:12649176, ECO:0000269|PubMed:14599745, ECO:0000269|PubMed:14612514, ECO:0000269|PubMed:14627815, ECO:0000269|PubMed:14704337, ECO:0000269|PubMed:14734805, ECO:0000269|PubMed:15177042, ECO:0000269|PubMed:15262962, ECO:0000269|PubMed:15574326, ECO:0000269|PubMed:1597196, ECO:0000269|PubMed:16046194, ECO:0000269|PubMed:16397295, ECO:0000269|PubMed:18644470, ECO:0000269|PubMed:2247066, ECO:0000269|PubMed:2507541, ECO:0000269|PubMed:26237645, ECO:0000269|PubMed:26666690, ECO:0000269|PubMed:28712728, ECO:0000269|PubMed:29478807, ECO:0000269|PubMed:30247612, ECO:0000269|PubMed:32103174, ECO:0000269|PubMed:33273464, ECO:0000269|PubMed:33854234, ECO:0000269|PubMed:34352203, ECO:0000269|PubMed:35460603, ECO:0000269|PubMed:8407951, ECO:0000269|PubMed:8464713, ECO:0000269|PubMed:9139719, ECO:0000269|PubMed:9362500, ECO:0000269|PubMed:9363941, ECO:0000269|PubMed:9679063}. |
Q08AM6 | VAC14 | S743 | ochoa | Protein VAC14 homolog (Tax1-binding protein 2) | Scaffold protein component of the PI(3,5)P2 regulatory complex which regulates both the synthesis and turnover of phosphatidylinositol 3,5-bisphosphate (PtdIns(3,5)P2). Pentamerizes into a star-shaped structure and nucleates the assembly of the complex. The pentamer binds a single copy each of PIKFYVE and FIG4 and coordinates both PIKfyve kinase activity and FIG4 phosphatase activity, being required to maintain normal levels of phosphatidylinositol 3-phosphate (PtdIns(3)P) and phosphatidylinositol 5-phosphate (PtdIns(5)P) (PubMed:33098764). Plays a role in the biogenesis of endosome carrier vesicles (ECV) / multivesicular bodies (MVB) transport intermediates from early endosomes. {ECO:0000269|PubMed:15542851, ECO:0000269|PubMed:17556371, ECO:0000269|PubMed:33098764}. |
Q09019 | DMWD | S652 | ochoa | Dystrophia myotonica WD repeat-containing protein (Dystrophia myotonica-containing WD repeat motif protein) (Protein 59) (Protein DMR-N9) | Regulator of the deubiquitinating USP12/DMWD/WDR48 complex (PubMed:33844468). Functions as a cofactor that promotes USP12 enzymatic activity (PubMed:33844468). {ECO:0000269|PubMed:33844468}. |
Q12888 | TP53BP1 | S552 | ochoa|psp | TP53-binding protein 1 (53BP1) (p53-binding protein 1) (p53BP1) | Double-strand break (DSB) repair protein involved in response to DNA damage, telomere dynamics and class-switch recombination (CSR) during antibody genesis (PubMed:12364621, PubMed:17190600, PubMed:21144835, PubMed:22553214, PubMed:23333306, PubMed:27153538, PubMed:28241136, PubMed:31135337, PubMed:37696958). Plays a key role in the repair of double-strand DNA breaks (DSBs) in response to DNA damage by promoting non-homologous end joining (NHEJ)-mediated repair of DSBs and specifically counteracting the function of the homologous recombination (HR) repair protein BRCA1 (PubMed:22553214, PubMed:23333306, PubMed:23727112, PubMed:27153538, PubMed:31135337). In response to DSBs, phosphorylation by ATM promotes interaction with RIF1 and dissociation from NUDT16L1/TIRR, leading to recruitment to DSBs sites (PubMed:28241136). Recruited to DSBs sites by recognizing and binding histone H2A monoubiquitinated at 'Lys-15' (H2AK15Ub) and histone H4 dimethylated at 'Lys-20' (H4K20me2), two histone marks that are present at DSBs sites (PubMed:17190600, PubMed:23760478, PubMed:27153538, PubMed:28241136). Required for immunoglobulin class-switch recombination (CSR) during antibody genesis, a process that involves the generation of DNA DSBs (PubMed:23345425). Participates in the repair and the orientation of the broken DNA ends during CSR (By similarity). In contrast, it is not required for classic NHEJ and V(D)J recombination (By similarity). Promotes NHEJ of dysfunctional telomeres via interaction with PAXIP1 (PubMed:23727112). {ECO:0000250|UniProtKB:P70399, ECO:0000269|PubMed:12364621, ECO:0000269|PubMed:17190600, ECO:0000269|PubMed:21144835, ECO:0000269|PubMed:22553214, ECO:0000269|PubMed:23333306, ECO:0000269|PubMed:23345425, ECO:0000269|PubMed:23727112, ECO:0000269|PubMed:23760478, ECO:0000269|PubMed:27153538, ECO:0000269|PubMed:28241136, ECO:0000269|PubMed:31135337, ECO:0000269|PubMed:37696958}. |
Q13177 | PAK2 | S152 | ochoa | Serine/threonine-protein kinase PAK 2 (EC 2.7.11.1) (Gamma-PAK) (PAK65) (S6/H4 kinase) (p21-activated kinase 2) (PAK-2) (p58) [Cleaved into: PAK-2p27 (p27); PAK-2p34 (p34) (C-t-PAK2)] | Serine/threonine protein kinase that plays a role in a variety of different signaling pathways including cytoskeleton regulation, cell motility, cell cycle progression, apoptosis or proliferation (PubMed:12853446, PubMed:16617111, PubMed:19273597, PubMed:19923322, PubMed:33693784, PubMed:7744004, PubMed:9171063). Acts as a downstream effector of the small GTPases CDC42 and RAC1 (PubMed:7744004). Activation by the binding of active CDC42 and RAC1 results in a conformational change and a subsequent autophosphorylation on several serine and/or threonine residues (PubMed:7744004). Full-length PAK2 stimulates cell survival and cell growth (PubMed:7744004). Phosphorylates MAPK4 and MAPK6 and activates the downstream target MAPKAPK5, a regulator of F-actin polymerization and cell migration (PubMed:21317288). Phosphorylates JUN and plays an important role in EGF-induced cell proliferation (PubMed:21177766). Phosphorylates many other substrates including histone H4 to promote assembly of H3.3 and H4 into nucleosomes, BAD, ribosomal protein S6, or MBP (PubMed:21724829). Phosphorylates CASP7, thereby preventing its activity (PubMed:21555521, PubMed:27889207). Additionally, associates with ARHGEF7 and GIT1 to perform kinase-independent functions such as spindle orientation control during mitosis (PubMed:19273597, PubMed:19923322). On the other hand, apoptotic stimuli such as DNA damage lead to caspase-mediated cleavage of PAK2, generating PAK-2p34, an active p34 fragment that translocates to the nucleus and promotes cellular apoptosis involving the JNK signaling pathway (PubMed:12853446, PubMed:16617111, PubMed:9171063). Caspase-activated PAK2 phosphorylates MKNK1 and reduces cellular translation (PubMed:15234964). {ECO:0000269|PubMed:12853446, ECO:0000269|PubMed:15234964, ECO:0000269|PubMed:16617111, ECO:0000269|PubMed:19273597, ECO:0000269|PubMed:19923322, ECO:0000269|PubMed:21177766, ECO:0000269|PubMed:21317288, ECO:0000269|PubMed:21555521, ECO:0000269|PubMed:21724829, ECO:0000269|PubMed:27889207, ECO:0000269|PubMed:33693784, ECO:0000269|PubMed:7744004, ECO:0000269|PubMed:9171063}. |
Q13568 | IRF5 | S301 | psp | Interferon regulatory factor 5 (IRF-5) | Transcription factor that plays a critical role in innate immunity by activating expression of type I interferon (IFN) IFNA and INFB and inflammatory cytokines downstream of endolysosomal toll-like receptors TLR7, TLR8 and TLR9 (PubMed:11303025, PubMed:15695821, PubMed:22412986, PubMed:25326418, PubMed:32433612). Regulates the transcription of type I IFN genes (IFN-alpha and IFN-beta) and IFN-stimulated genes (ISG) by binding to an interferon-stimulated response element (ISRE) in their promoters (By similarity). Can efficiently activate both the IFN-beta (IFNB) and the IFN-alpha (IFNA) genes and mediate their induction downstream of the TLR-activated, MyD88-dependent pathway (By similarity). Key transcription factor regulating the IFN response during SARS-CoV-2 infection (PubMed:33440148). {ECO:0000250|UniProtKB:P56477, ECO:0000269|PubMed:11303025, ECO:0000269|PubMed:15695821, ECO:0000269|PubMed:22412986, ECO:0000269|PubMed:25326418, ECO:0000269|PubMed:32433612, ECO:0000269|PubMed:33440148}. |
Q13796 | SHROOM2 | S1297 | ochoa | Protein Shroom2 (Apical-like protein) (Protein APXL) | May be involved in endothelial cell morphology changes during cell spreading. In the retinal pigment epithelium, may regulate the biogenesis of melanosomes and promote their association with the apical cell surface by inducing gamma-tubulin redistribution (By similarity). {ECO:0000250}. |
Q15262 | PTPRK | S828 | ochoa | Receptor-type tyrosine-protein phosphatase kappa (Protein-tyrosine phosphatase kappa) (R-PTP-kappa) (EC 3.1.3.48) | Regulation of processes involving cell contact and adhesion such as growth control, tumor invasion, and metastasis. Negative regulator of EGFR signaling pathway. Forms complexes with beta-catenin and gamma-catenin/plakoglobin. Beta-catenin may be a substrate for the catalytic activity of PTPRK/PTP-kappa. {ECO:0000269|PubMed:19836242}. |
Q16236 | NFE2L2 | S577 | psp | Nuclear factor erythroid 2-related factor 2 (NF-E2-related factor 2) (NFE2-related factor 2) (Nrf-2) (Nuclear factor, erythroid derived 2, like 2) | Transcription factor that plays a key role in the response to oxidative stress: binds to antioxidant response (ARE) elements present in the promoter region of many cytoprotective genes, such as phase 2 detoxifying enzymes, and promotes their expression, thereby neutralizing reactive electrophiles (PubMed:11035812, PubMed:19489739, PubMed:29018201, PubMed:31398338). In normal conditions, ubiquitinated and degraded in the cytoplasm by the BCR(KEAP1) complex (PubMed:11035812, PubMed:15601839, PubMed:29018201). In response to oxidative stress, electrophile metabolites inhibit activity of the BCR(KEAP1) complex, promoting nuclear accumulation of NFE2L2/NRF2, heterodimerization with one of the small Maf proteins and binding to ARE elements of cytoprotective target genes (PubMed:19489739, PubMed:29590092). The NFE2L2/NRF2 pathway is also activated in response to selective autophagy: autophagy promotes interaction between KEAP1 and SQSTM1/p62 and subsequent inactivation of the BCR(KEAP1) complex, leading to NFE2L2/NRF2 nuclear accumulation and expression of cytoprotective genes (PubMed:20452972). The NFE2L2/NRF2 pathway is also activated during the unfolded protein response (UPR), contributing to redox homeostasis and cell survival following endoplasmic reticulum stress (By similarity). May also be involved in the transcriptional activation of genes of the beta-globin cluster by mediating enhancer activity of hypersensitive site 2 of the beta-globin locus control region (PubMed:7937919). Also plays an important role in the regulation of the innate immune response and antiviral cytosolic DNA sensing. It is a critical regulator of the innate immune response and survival during sepsis by maintaining redox homeostasis and restraint of the dysregulation of pro-inflammatory signaling pathways like MyD88-dependent and -independent and TNF-alpha signaling (By similarity). Suppresses macrophage inflammatory response by blocking pro-inflammatory cytokine transcription and the induction of IL6 (By similarity). Binds to the proximity of pro-inflammatory genes in macrophages and inhibits RNA Pol II recruitment. The inhibition is independent of the NRF2-binding motif and reactive oxygen species level (By similarity). Represses antiviral cytosolic DNA sensing by suppressing the expression of the adapter protein STING1 and decreasing responsiveness to STING1 agonists while increasing susceptibility to infection with DNA viruses (PubMed:30158636). Once activated, limits the release of pro-inflammatory cytokines in response to human coronavirus SARS-CoV-2 infection and to virus-derived ligands through a mechanism that involves inhibition of IRF3 dimerization. Also inhibits both SARS-CoV-2 replication, as well as the replication of several other pathogenic viruses including Herpes Simplex Virus-1 and-2, Vaccinia virus, and Zika virus through a type I interferon (IFN)-independent mechanism (PubMed:33009401). {ECO:0000250|UniProtKB:Q60795, ECO:0000269|PubMed:11035812, ECO:0000269|PubMed:15601839, ECO:0000269|PubMed:19489739, ECO:0000269|PubMed:20452972, ECO:0000269|PubMed:29018201, ECO:0000269|PubMed:29590092, ECO:0000269|PubMed:30158636, ECO:0000269|PubMed:31398338, ECO:0000269|PubMed:33009401, ECO:0000269|PubMed:7937919}. |
Q16649 | NFIL3 | S353 | ochoa | Nuclear factor interleukin-3-regulated protein (E4 promoter-binding protein 4) (Interleukin-3 promoter transcriptional activator) (Interleukin-3-binding protein 1) (Transcriptional activator NF-IL3A) | Acts as a transcriptional regulator that recognizes and binds to the sequence 5'-[GA]TTA[CT]GTAA[CT]-3', a sequence present in many cellular and viral promoters. Represses transcription from promoters with activating transcription factor (ATF) sites. Represses promoter activity in osteoblasts (By similarity). Represses transcriptional activity of PER1 (By similarity). Represses transcriptional activity of PER2 via the B-site on the promoter (By similarity). Activates transcription from the interleukin-3 promoter in T-cells. Competes for the same consensus-binding site with PAR DNA-binding factors (DBP, HLF and TEF) (By similarity). Component of the circadian clock that acts as a negative regulator for the circadian expression of PER2 oscillation in the cell-autonomous core clock (By similarity). Protects pro-B cells from programmed cell death (By similarity). Represses the transcription of CYP2A5 (By similarity). Positively regulates the expression and activity of CES2 by antagonizing the repressive action of NR1D1 on CES2 (By similarity). Required for the development of natural killer cell precursors (By similarity). {ECO:0000250|UniProtKB:O08750, ECO:0000269|PubMed:1620116, ECO:0000269|PubMed:7565758, ECO:0000269|PubMed:8836190}. |
Q2M3V2 | SOWAHA | S252 | ochoa | Ankyrin repeat domain-containing protein SOWAHA (Ankyrin repeat domain-containing protein 43) (Protein sosondowah homolog A) | None |
Q2TB10 | ZNF800 | S419 | ochoa | Zinc finger protein 800 | May be involved in transcriptional regulation. |
Q5SVQ8 | ZBTB41 | S191 | ochoa | Zinc finger and BTB domain-containing protein 41 | May be involved in transcriptional regulation. |
Q5T0W9 | FAM83B | S915 | ochoa | Protein FAM83B | Probable proto-oncogene that functions in the epidermal growth factor receptor/EGFR signaling pathway. Activates both the EGFR itself and downstream RAS/MAPK and PI3K/AKT/TOR signaling cascades. {ECO:0000269|PubMed:22886302, ECO:0000269|PubMed:23676467, ECO:0000269|PubMed:23912460}. |
Q5T481 | RBM20 | S1120 | ochoa | RNA-binding protein 20 (RNA-binding motif protein 20) | RNA-binding protein that acts as a regulator of mRNA splicing of a subset of genes encoding key structural proteins involved in cardiac development, such as TTN (Titin), CACNA1C, CAMK2D or PDLIM5/ENH (PubMed:22466703, PubMed:24960161, PubMed:26604136, PubMed:27496873, PubMed:27531932, PubMed:29895960, PubMed:30948719, PubMed:32840935, PubMed:34732726, PubMed:35427468). Acts as a repressor of mRNA splicing: specifically binds the 5'UCUU-3' motif that is predominantly found within intronic sequences of pre-mRNAs, leading to the exclusion of specific exons in target transcripts (PubMed:24960161, PubMed:30948719, PubMed:34732726). RBM20-mediated exon skipping is hormone-dependent and is essential for TTN isoform transition in both cardiac and skeletal muscles (PubMed:27531932, PubMed:30948719). RBM20-mediated exon skipping of TTN provides substrates for the formation of circular RNA (circRNAs) from the TTN transcripts (PubMed:27531932, PubMed:34732726). Together with RBM24, promotes the expression of short isoforms of PDLIM5/ENH in cardiomyocytes (By similarity). {ECO:0000250|UniProtKB:E9PT37, ECO:0000269|PubMed:22466703, ECO:0000269|PubMed:24960161, ECO:0000269|PubMed:26604136, ECO:0000269|PubMed:27496873, ECO:0000269|PubMed:27531932, ECO:0000269|PubMed:29895960, ECO:0000269|PubMed:30948719, ECO:0000269|PubMed:32840935, ECO:0000269|PubMed:34732726, ECO:0000269|PubMed:35427468}. |
Q5VT25 | CDC42BPA | S674 | ochoa | Serine/threonine-protein kinase MRCK alpha (EC 2.7.11.1) (CDC42-binding protein kinase alpha) (DMPK-like alpha) (Myotonic dystrophy kinase-related CDC42-binding kinase alpha) (MRCK alpha) (Myotonic dystrophy protein kinase-like alpha) | Serine/threonine-protein kinase which is an important downstream effector of CDC42 and plays a role in the regulation of cytoskeleton reorganization and cell migration (PubMed:15723050, PubMed:9092543, PubMed:9418861). Regulates actin cytoskeletal reorganization via phosphorylation of PPP1R12C and MYL9/MLC2 (PubMed:21457715). In concert with MYO18A and LURAP1, is involved in modulating lamellar actomyosin retrograde flow that is crucial to cell protrusion and migration (PubMed:18854160). Phosphorylates: PPP1R12A, LIMK1 and LIMK2 (PubMed:11340065, PubMed:11399775). May play a role in TFRC-mediated iron uptake (PubMed:20188707). In concert with FAM89B/LRAP25 mediates the targeting of LIMK1 to the lamellipodium resulting in its activation and subsequent phosphorylation of CFL1 which is important for lamellipodial F-actin regulation (By similarity). Triggers the formation of an extrusion apical actin ring required for epithelial extrusion of apoptotic cells (PubMed:29162624). {ECO:0000250|UniProtKB:Q3UU96, ECO:0000269|PubMed:11340065, ECO:0000269|PubMed:11399775, ECO:0000269|PubMed:15723050, ECO:0000269|PubMed:18854160, ECO:0000269|PubMed:20188707, ECO:0000269|PubMed:21457715, ECO:0000269|PubMed:29162624, ECO:0000269|PubMed:9092543, ECO:0000269|PubMed:9418861}. |
Q68DQ2 | CRYBG3 | S716 | ochoa | Very large A-kinase anchor protein (vlAKAP) (Beta/gamma crystallin domain-containing protein 3) | [Isoform vlAKAP]: Anchoring protein that mediates the subcellular compartmentation of protein kinase A (PKA). {ECO:0000269|PubMed:25097019}. |
Q6KC79 | NIPBL | S103 | ochoa | Nipped-B-like protein (Delangin) (SCC2 homolog) | Plays an important role in the loading of the cohesin complex on to DNA. Forms a heterodimeric complex (also known as cohesin loading complex) with MAU2/SCC4 which mediates the loading of the cohesin complex onto chromatin (PubMed:22628566, PubMed:28914604). Plays a role in cohesin loading at sites of DNA damage. Its recruitment to double-strand breaks (DSBs) sites occurs in a CBX3-, RNF8- and RNF168-dependent manner whereas its recruitment to UV irradiation-induced DNA damage sites occurs in a ATM-, ATR-, RNF8- and RNF168-dependent manner (PubMed:28167679). Along with ZNF609, promotes cortical neuron migration during brain development by regulating the transcription of crucial genes in this process. Preferentially binds promoters containing paused RNA polymerase II. Up-regulates the expression of SEMA3A, NRP1, PLXND1 and GABBR2 genes, among others (By similarity). {ECO:0000250|UniProtKB:Q6KCD5, ECO:0000269|PubMed:22628566, ECO:0000269|PubMed:28167679, ECO:0000269|PubMed:28914604}. |
Q6NXS1 | PPP1R2B | S130 | ochoa | Protein phosphatase inhibitor 2 family member B (PPP1R2 family member B) (Protein phosphatase 1, regulatory subunit 2 pseudogene 3) (Protein phosphatase inhibitor 2-like protein 3) | Inhibitor of protein-phosphatase 1. {ECO:0000269|PubMed:23506001}. |
Q6P0N0 | MIS18BP1 | S134 | ochoa | Mis18-binding protein 1 (Kinetochore-associated protein KNL-2 homolog) (HsKNL-2) (P243) | Required for recruitment of CENPA to centromeres and normal chromosome segregation during mitosis. {ECO:0000269|PubMed:17199038, ECO:0000269|PubMed:17339379}. |
Q6ZNJ1 | NBEAL2 | S1350 | ochoa | Neurobeachin-like protein 2 | Probably involved in thrombopoiesis. Plays a role in the development or secretion of alpha-granules, that contain several growth factors important for platelet biogenesis. {ECO:0000269|PubMed:21765411, ECO:0000269|PubMed:21765412}. |
Q711Q0 | CEFIP | S116 | ochoa | Cardiac-enriched FHL2-interacting protein | Plays an important role in cardiomyocyte hypertrophy via activation of the calcineurin/NFAT signaling pathway. {ECO:0000250|UniProtKB:M0RD54}. |
Q7Z2Z1 | TICRR | S1013 | ochoa | Treslin (TopBP1-interacting checkpoint and replication regulator) (TopBP1-interacting, replication-stimulating protein) | Regulator of DNA replication and S/M and G2/M checkpoints. Regulates the triggering of DNA replication initiation via its interaction with TOPBP1 by participating in CDK2-mediated loading of CDC45L onto replication origins. Required for the transition from pre-replication complex (pre-RC) to pre-initiation complex (pre-IC). Required to prevent mitotic entry after treatment with ionizing radiation. {ECO:0000269|PubMed:20116089}. |
Q7Z3J3 | RGPD4 | T1475 | ochoa | RanBP2-like and GRIP domain-containing protein 4 | None |
Q7Z4H7 | HAUS6 | S507 | ochoa | HAUS augmin-like complex subunit 6 | Contributes to mitotic spindle assembly, maintenance of centrosome integrity and completion of cytokinesis as part of the HAUS augmin-like complex. Promotes the nucleation of microtubules from the spindle through recruitment of NEDD1 and gamma-tubulin. {ECO:0000269|PubMed:19029337, ECO:0000269|PubMed:19369198, ECO:0000269|PubMed:19427217}. |
Q7Z6B7 | SRGAP1 | S196 | ochoa | SLIT-ROBO Rho GTPase-activating protein 1 (srGAP1) (Rho GTPase-activating protein 13) | GTPase-activating protein for RhoA and Cdc42 small GTPases. Together with CDC42 seems to be involved in the pathway mediating the repulsive signaling of Robo and Slit proteins in neuronal migration. SLIT2, probably through interaction with ROBO1, increases the interaction of SRGAP1 with ROBO1 and inactivates CDC42. {ECO:0000269|PubMed:11672528}. |
Q7Z7M9 | GALNT5 | S202 | ochoa | Polypeptide N-acetylgalactosaminyltransferase 5 (EC 2.4.1.41) (Polypeptide GalNAc transferase 5) (GalNAc-T5) (pp-GaNTase 5) (Protein-UDP acetylgalactosaminyltransferase 5) (UDP-GalNAc:polypeptide N-acetylgalactosaminyltransferase 5) | Catalyzes the initial reaction in O-linked oligosaccharide biosynthesis, the transfer of an N-acetyl-D-galactosamine residue to a serine or threonine residue on the protein receptor. Has activity toward EA2 peptide substrate, but has a weak activity toward Muc2 or Muc1b substrates (By similarity). {ECO:0000250}. |
Q86TU7 | SETD3 | S38 | ochoa | Actin-histidine N-methyltransferase (EC 2.1.1.85) (Protein-L-histidine N-tele-methyltransferase) (SET domain-containing protein 3) (hSETD3) | Protein-histidine N-methyltransferase that specifically mediates 3-methylhistidine (tele-methylhistidine) methylation of actin at 'His-73' (PubMed:30526847, PubMed:30626964, PubMed:30785395, PubMed:31388018, PubMed:31993215). Histidine methylation of actin is required for smooth muscle contraction of the laboring uterus during delivery (PubMed:30626964). Does not have protein-lysine N-methyltransferase activity and probably only catalyzes histidine methylation of actin (PubMed:30626964, PubMed:30785395, PubMed:31388018). {ECO:0000269|PubMed:30526847, ECO:0000269|PubMed:30626964, ECO:0000269|PubMed:30785395, ECO:0000269|PubMed:31388018, ECO:0000269|PubMed:31993215}. |
Q86UX7 | FERMT3 | S31 | ochoa | Fermitin family homolog 3 (Kindlin-3) (MIG2-like protein) (Unc-112-related protein 2) | Plays a central role in cell adhesion in hematopoietic cells (PubMed:19234463, PubMed:26359933). Acts by activating the integrin beta-1-3 (ITGB1, ITGB2 and ITGB3) (By similarity). Required for integrin-mediated platelet adhesion and leukocyte adhesion to endothelial cells (PubMed:19234460). Required for activation of integrin beta-2 (ITGB2) in polymorphonuclear granulocytes (PMNs) (By similarity). {ECO:0000250|UniProtKB:Q8K1B8, ECO:0000269|PubMed:19234460, ECO:0000269|PubMed:19234463, ECO:0000269|PubMed:26359933}.; FUNCTION: Isoform 2 may act as a repressor of NF-kappa-B and apoptosis. {ECO:0000269|PubMed:19064721, ECO:0000269|PubMed:19234460, ECO:0000269|PubMed:19234463}. |
Q8IXS8 | HYCC2 | S508 | ochoa | Hyccin 2 | Component of a complex required to localize phosphatidylinositol 4-kinase (PI4K) to the plasma membrane. {ECO:0000305|PubMed:26571211}. |
Q8IXT5 | RBM12B | S638 | ochoa | RNA-binding protein 12B (RNA-binding motif protein 12B) | None |
Q8IXT5 | RBM12B | S710 | ochoa | RNA-binding protein 12B (RNA-binding motif protein 12B) | None |
Q8IXT5 | RBM12B | S718 | ochoa | RNA-binding protein 12B (RNA-binding motif protein 12B) | None |
Q8IZD2 | KMT2E | S531 | ochoa | Inactive histone-lysine N-methyltransferase 2E (Inactive lysine N-methyltransferase 2E) (Myeloid/lymphoid or mixed-lineage leukemia protein 5) | Associates with chromatin regions downstream of transcriptional start sites of active genes and thus regulates gene transcription (PubMed:23629655, PubMed:23798402, PubMed:24130829). Chromatin interaction is mediated via the binding to tri-methylated histone H3 at 'Lys-4' (H3K4me3) (PubMed:23798402, PubMed:24130829). Key regulator of hematopoiesis involved in terminal myeloid differentiation and in the regulation of hematopoietic stem cell (HSCs) self-renewal by a mechanism that involves DNA methylation (By similarity). Also acts as an important cell cycle regulator, participating in cell cycle regulatory network machinery at multiple cell cycle stages including G1/S transition, S phase progression and mitotic entry (PubMed:14718661, PubMed:18573682, PubMed:19264965, PubMed:23629655). Recruited to E2F1 responsive promoters by HCFC1 where it stimulates tri-methylation of histone H3 at 'Lys-4' and transcriptional activation and thereby facilitates G1 to S phase transition (PubMed:23629655). During myoblast differentiation, required to suppress inappropriate expression of S-phase-promoting genes and maintain expression of determination genes in quiescent cells (By similarity). {ECO:0000250|UniProtKB:Q3UG20, ECO:0000269|PubMed:14718661, ECO:0000269|PubMed:18573682, ECO:0000269|PubMed:23629655, ECO:0000269|PubMed:23798402, ECO:0000269|PubMed:24130829}.; FUNCTION: [Isoform NKp44L]: Cellular ligand for NCR2/NKp44, may play a role as a danger signal in cytotoxicity and NK-cell-mediated innate immunity. {ECO:0000269|PubMed:23958951}. |
Q8NB16 | MLKL | S125 | ochoa | Mixed lineage kinase domain-like protein (hMLKL) | Pseudokinase that plays a key role in TNF-induced necroptosis, a programmed cell death process (PubMed:22265413, PubMed:22265414, PubMed:22421439, PubMed:24316671). Does not have protein kinase activity (PubMed:22265413, PubMed:22265414, PubMed:22421439, PubMed:24316671). Activated following phosphorylation by RIPK3, leading to homotrimerization, localization to the plasma membrane and execution of programmed necrosis characterized by calcium influx and plasma membrane damage (PubMed:22265413, PubMed:22265414, PubMed:22421439, PubMed:24316671). In addition to TNF-induced necroptosis, necroptosis can also take place in the nucleus in response to orthomyxoviruses infection: following activation by ZBP1, MLKL is phosphorylated by RIPK3 in the nucleus, triggering disruption of the nuclear envelope and leakage of cellular DNA into the cytosol.following ZBP1 activation, which senses double-stranded Z-RNA structures, nuclear RIPK3 catalyzes phosphorylation and activation of MLKL, promoting disruption of the nuclear envelope and leakage of cellular DNA into the cytosol (By similarity). Binds to highly phosphorylated inositol phosphates such as inositolhexakisphosphate (InsP6) which is essential for its necroptotic function (PubMed:29883610). {ECO:0000250|UniProtKB:Q9D2Y4, ECO:0000269|PubMed:22265413, ECO:0000269|PubMed:22265414, ECO:0000269|PubMed:22421439, ECO:0000269|PubMed:24316671, ECO:0000269|PubMed:29883610}. |
Q8TE68 | EPS8L1 | Y684 | ochoa | Epidermal growth factor receptor kinase substrate 8-like protein 1 (EPS8-like protein 1) (Epidermal growth factor receptor pathway substrate 8-related protein 1) (EPS8-related protein 1) | Stimulates guanine exchange activity of SOS1. May play a role in membrane ruffling and remodeling of the actin cytoskeleton. {ECO:0000269|PubMed:14565974}. |
Q8TF72 | SHROOM3 | S443 | ochoa | Protein Shroom3 (Shroom-related protein) (hShrmL) | Controls cell shape changes in the neuroepithelium during neural tube closure. Induces apical constriction in epithelial cells by promoting the apical accumulation of F-actin and myosin II, and probably by bundling stress fibers (By similarity). Induces apicobasal cell elongation by redistributing gamma-tubulin and directing the assembly of robust apicobasal microtubule arrays (By similarity). {ECO:0000250|UniProtKB:Q27IV2, ECO:0000250|UniProtKB:Q9QXN0}. |
Q92576 | PHF3 | S125 | ochoa | PHD finger protein 3 | None |
Q93009 | USP7 | S963 | ochoa | Ubiquitin carboxyl-terminal hydrolase 7 (EC 3.4.19.12) (Deubiquitinating enzyme 7) (Herpesvirus-associated ubiquitin-specific protease) (Ubiquitin thioesterase 7) (Ubiquitin-specific-processing protease 7) | Hydrolase that deubiquitinates target proteins such as ARMC5, FOXO4, DEPTOR, KAT5, p53/TP53, MDM2, ERCC6, DNMT1, UHRF1, PTEN, KMT2E/MLL5 and DAXX (PubMed:11923872, PubMed:15053880, PubMed:16964248, PubMed:18716620, PubMed:25283148, PubMed:25865756, PubMed:26678539, PubMed:28655758, PubMed:33544460, PubMed:35216969). Together with DAXX, prevents MDM2 self-ubiquitination and enhances the E3 ligase activity of MDM2 towards p53/TP53, thereby promoting p53/TP53 ubiquitination and proteasomal degradation (PubMed:15053880, PubMed:16845383, PubMed:18566590, PubMed:20153724). Deubiquitinates p53/TP53, preventing degradation of p53/TP53, and enhances p53/TP53-dependent transcription regulation, cell growth repression and apoptosis (PubMed:25283148). Deubiquitinates p53/TP53 and MDM2 and strongly stabilizes p53/TP53 even in the presence of excess MDM2, and also induces p53/TP53-dependent cell growth repression and apoptosis (PubMed:11923872, PubMed:26786098). Deubiquitination of FOXO4 in presence of hydrogen peroxide is not dependent on p53/TP53 and inhibits FOXO4-induced transcriptional activity (PubMed:16964248). In association with DAXX, is involved in the deubiquitination and translocation of PTEN from the nucleus to the cytoplasm, both processes that are counteracted by PML (PubMed:18716620). Deubiquitinates KMT2E/MLL5 preventing KMT2E/MLL5 proteasomal-mediated degradation (PubMed:26678539). Involved in cell proliferation during early embryonic development. Involved in transcription-coupled nucleotide excision repair (TC-NER) in response to UV damage: recruited to DNA damage sites following interaction with KIAA1530/UVSSA and promotes deubiquitination of ERCC6, preventing UV-induced degradation of ERCC6 (PubMed:22466611, PubMed:22466612). Involved in maintenance of DNA methylation via its interaction with UHRF1 and DNMT1: acts by mediating deubiquitination of UHRF1 and DNMT1, preventing their degradation and promoting DNA methylation by DNMT1 (PubMed:21745816, PubMed:22411829). Deubiquitinates alkylation repair enzyme ALKBH3. OTUD4 recruits USP7 and USP9X to stabilize ALKBH3, thereby promoting the repair of alkylated DNA lesions (PubMed:25944111). Acts as a chromatin regulator via its association with the Polycomb group (PcG) multiprotein PRC1-like complex; may act by deubiquitinating components of the PRC1-like complex (PubMed:20601937). Able to mediate deubiquitination of histone H2B; it is however unsure whether this activity takes place in vivo (PubMed:20601937). Exhibits a preference towards 'Lys-48'-linked ubiquitin chains (PubMed:22689415). Increases regulatory T-cells (Treg) suppressive capacity by deubiquitinating and stabilizing the transcription factor FOXP3 which is crucial for Treg cell function (PubMed:23973222). Plays a role in the maintenance of the circadian clock periodicity via deubiquitination and stabilization of the CRY1 and CRY2 proteins (PubMed:27123980). Deubiquitinates REST, thereby stabilizing REST and promoting the maintenance of neural progenitor cells (PubMed:21258371). Deubiquitinates SIRT7, inhibiting SIRT7 histone deacetylase activity and regulating gluconeogenesis (PubMed:28655758). Involved in the regulation of WASH-dependent actin polymerization at the surface of endosomes and the regulation of endosomal protein recycling (PubMed:26365382). It maintains optimal WASH complex activity and precise F-actin levels via deubiquitination of TRIM27 and WASHC1 (PubMed:26365382). Mediates the deubiquitination of phosphorylated DEPTOR, promoting its stability and leading to decreased mTORC1 signaling (PubMed:35216969). {ECO:0000269|PubMed:11923872, ECO:0000269|PubMed:15053880, ECO:0000269|PubMed:16845383, ECO:0000269|PubMed:16964248, ECO:0000269|PubMed:18566590, ECO:0000269|PubMed:18716620, ECO:0000269|PubMed:20153724, ECO:0000269|PubMed:20601937, ECO:0000269|PubMed:21258371, ECO:0000269|PubMed:21745816, ECO:0000269|PubMed:22411829, ECO:0000269|PubMed:22466611, ECO:0000269|PubMed:22466612, ECO:0000269|PubMed:22689415, ECO:0000269|PubMed:23973222, ECO:0000269|PubMed:25283148, ECO:0000269|PubMed:25865756, ECO:0000269|PubMed:25944111, ECO:0000269|PubMed:26365382, ECO:0000269|PubMed:26678539, ECO:0000269|PubMed:26786098, ECO:0000269|PubMed:27123980, ECO:0000269|PubMed:28655758, ECO:0000269|PubMed:33544460, ECO:0000269|PubMed:35216969}.; FUNCTION: (Microbial infection) Contributes to the overall stabilization and trans-activation capability of the herpesvirus 1 trans-acting transcriptional protein ICP0/VMW110 during HSV-1 infection. {ECO:0000269|PubMed:14506283, ECO:0000269|PubMed:16160161, ECO:0000269|PubMed:18590780}.; FUNCTION: (Microbial infection) Upon infection with Epstein-Barr virus, the interaction with viral EBNA1 increases the association of USP7 with PML proteins, which is required for the polyubiquitylation and degradation of PML. {ECO:0000269|PubMed:20719947, ECO:0000269|PubMed:24216761}. |
Q96GX5 | MASTL | S619 | ochoa | Serine/threonine-protein kinase greatwall (GW) (GWL) (hGWL) (EC 2.7.11.1) (Microtubule-associated serine/threonine-protein kinase-like) (MAST-L) | Serine/threonine kinase that plays a key role in M phase by acting as a regulator of mitosis entry and maintenance (PubMed:19680222). Acts by promoting the inactivation of protein phosphatase 2A (PP2A) during M phase: does not directly inhibit PP2A but acts by mediating phosphorylation and subsequent activation of ARPP19 and ENSA at 'Ser-62' and 'Ser-67', respectively (PubMed:38123684). ARPP19 and ENSA are phosphatase inhibitors that specifically inhibit the PPP2R2D (PR55-delta) subunit of PP2A. Inactivation of PP2A during M phase is essential to keep cyclin-B1-CDK1 activity high (PubMed:20818157). Following DNA damage, it is also involved in checkpoint recovery by being inhibited. Phosphorylates histone protein in vitro; however such activity is unsure in vivo. May be involved in megakaryocyte differentiation. {ECO:0000269|PubMed:12890928, ECO:0000269|PubMed:19680222, ECO:0000269|PubMed:19793917, ECO:0000269|PubMed:20538976, ECO:0000269|PubMed:20818157, ECO:0000269|PubMed:38123684}. |
Q96K31 | C8orf76 | S25 | ochoa | Uncharacterized protein C8orf76 | None |
Q96K83 | ZNF521 | S273 | ochoa | Zinc finger protein 521 (Early hematopoietic zinc finger protein) (LYST-interacting protein 3) | Transcription factor that can both act as an activator or a repressor depending on the context. Involved in BMP signaling and in the regulation of the immature compartment of the hematopoietic system. Associates with SMADs in response to BMP2 leading to activate transcription of BMP target genes. Acts as a transcriptional repressor via its interaction with EBF1, a transcription factor involved specification of B-cell lineage; this interaction preventing EBF1 to bind DNA and activate target genes. {ECO:0000269|PubMed:14630787}. |
Q96KP1 | EXOC2 | S404 | ochoa | Exocyst complex component 2 (Exocyst complex component Sec5) | Component of the exocyst complex involved in the docking of exocytic vesicles with fusion sites on the plasma membrane. {ECO:0000269|PubMed:12459492, ECO:0000269|PubMed:32639540}. |
Q96R06 | SPAG5 | S835 | ochoa | Sperm-associated antigen 5 (Astrin) (Deepest) (Mitotic spindle-associated protein p126) (MAP126) | Essential component of the mitotic spindle required for normal chromosome segregation and progression into anaphase (PubMed:11724960, PubMed:12356910, PubMed:27462074). Required for chromosome alignment, normal timing of sister chromatid segregation, and maintenance of spindle pole architecture (PubMed:17664331, PubMed:27462074). In complex with SKAP, promotes stable microtubule-kinetochore attachments. May contribute to the regulation of separase activity. May regulate AURKA localization to mitotic spindle, but not to centrosomes and CCNB1 localization to both mitotic spindle and centrosomes (PubMed:18361916, PubMed:21402792). Involved in centriole duplication. Required for CDK5RAP2, CEP152, WDR62 and CEP63 centrosomal localization and promotes the centrosomal localization of CDK2 (PubMed:26297806). In non-mitotic cells, upon stress induction, inhibits mammalian target of rapamycin complex 1 (mTORC1) association and recruits the mTORC1 component RPTOR to stress granules (SGs), thereby preventing mTORC1 hyperactivation-induced apoptosis (PubMed:23953116). May enhance GSK3B-mediated phosphorylation of other substrates, such as MAPT/TAU (PubMed:18055457). {ECO:0000269|PubMed:12356910, ECO:0000269|PubMed:17664331, ECO:0000269|PubMed:18055457, ECO:0000269|PubMed:18361916, ECO:0000269|PubMed:21402792, ECO:0000269|PubMed:23953116, ECO:0000269|PubMed:26297806, ECO:0000269|PubMed:27462074, ECO:0000305|PubMed:11724960}. |
Q99666 | RGPD5 | T1474 | ochoa | RANBP2-like and GRIP domain-containing protein 5/6 (Ran-binding protein 2-like 1/2) (RanBP2-like 1/2) (RanBP2L1) (RanBP2L2) (Sperm membrane protein BS-63) | None |
Q99708 | RBBP8 | S276 | psp | DNA endonuclease RBBP8 (EC 3.1.-.-) (CtBP-interacting protein) (CtIP) (Retinoblastoma-binding protein 8) (RBBP-8) (Retinoblastoma-interacting protein and myosin-like) (RIM) (Sporulation in the absence of SPO11 protein 2 homolog) (SAE2) | Endonuclease that cooperates with the MRE11-RAD50-NBN (MRN) complex in DNA-end resection, the first step of double-strand break (DSB) repair through the homologous recombination (HR) pathway (PubMed:17965729, PubMed:19202191, PubMed:19759395, PubMed:20064462, PubMed:23273981, PubMed:26721387, PubMed:27814491, PubMed:27889449, PubMed:30787182). HR is restricted to S and G2 phases of the cell cycle and preferentially repairs DSBs resulting from replication fork collapse (PubMed:17965729, PubMed:19202191, PubMed:23273981, PubMed:27814491, PubMed:27889449, PubMed:30787182). Key determinant of DSB repair pathway choice, as it commits cells to HR by preventing classical non-homologous end-joining (NHEJ) (PubMed:19202191). Specifically promotes the endonuclease activity of the MRN complex to clear DNA ends containing protein adducts: recruited to DSBs by NBN following phosphorylation by CDK1, and promotes the endonuclease activity of MRE11 to clear protein-DNA adducts and generate clean double-strand break ends (PubMed:27814491, PubMed:27889449, PubMed:30787182, PubMed:33836577). Functions downstream of the MRN complex and ATM, promotes ATR activation and its recruitment to DSBs in the S/G2 phase facilitating the generation of ssDNA (PubMed:16581787, PubMed:17965729, PubMed:19759395, PubMed:20064462). Component of the BRCA1-RBBP8 complex that regulates CHEK1 activation and controls cell cycle G2/M checkpoints on DNA damage (PubMed:15485915, PubMed:16818604). During immunoglobulin heavy chain class-switch recombination, promotes microhomology-mediated alternative end joining (A-NHEJ) and plays an essential role in chromosomal translocations (By similarity). Binds preferentially to DNA Y-junctions and to DNA substrates with blocked ends and promotes intermolecular DNA bridging (PubMed:30601117). {ECO:0000250|UniProtKB:Q80YR6, ECO:0000269|PubMed:15485915, ECO:0000269|PubMed:16581787, ECO:0000269|PubMed:16818604, ECO:0000269|PubMed:17965729, ECO:0000269|PubMed:19202191, ECO:0000269|PubMed:19759395, ECO:0000269|PubMed:20064462, ECO:0000269|PubMed:23273981, ECO:0000269|PubMed:26721387, ECO:0000269|PubMed:27814491, ECO:0000269|PubMed:27889449, ECO:0000269|PubMed:30601117, ECO:0000269|PubMed:30787182, ECO:0000269|PubMed:33836577}. |
Q9BUG6 | ZSCAN5A | S245 | ochoa | Zinc finger and SCAN domain-containing protein 5A (Zinc finger protein 495) | May be involved in transcriptional regulation. |
Q9BVA0 | KATNB1 | S360 | ochoa | Katanin p80 WD40 repeat-containing subunit B1 (Katanin p80 subunit B1) (p80 katanin) | Participates in a complex which severs microtubules in an ATP-dependent manner. May act to target the enzymatic subunit of this complex to sites of action such as the centrosome. Microtubule severing may promote rapid reorganization of cellular microtubule arrays and the release of microtubules from the centrosome following nucleation. Microtubule release from the mitotic spindle poles may allow depolymerization of the microtubule end proximal to the spindle pole, leading to poleward microtubule flux and poleward motion of chromosome. Microtubule release within the cell body of neurons may be required for their transport into neuronal processes by microtubule-dependent motor proteins. This transport is required for axonal growth. {ECO:0000255|HAMAP-Rule:MF_03022, ECO:0000269|PubMed:10751153}. |
Q9BW04 | SARG | S580 | ochoa | Specifically androgen-regulated gene protein | Putative androgen-specific receptor. {ECO:0000269|PubMed:15525603}. |
Q9BY89 | KIAA1671 | S1224 | ochoa | Uncharacterized protein KIAA1671 | None |
Q9BZK3 | NACA4P | S113 | ochoa | Putative nascent polypeptide-associated complex subunit alpha-like protein (Alpha-NAC pseudogene 1) (NAC-alpha pseudogene 1) (NACA family member 4, pseudogene) | None |
Q9C0D2 | CEP295 | S1388 | ochoa | Centrosomal protein of 295 kDa | Centriole-enriched microtubule-binding protein involved in centriole biogenesis (PubMed:20844083, PubMed:25131205, PubMed:27185865, PubMed:38154379). Essential for the generation of the distal portion of new-born centrioles in a CPAP- and CEP120-mediated elongation dependent manner during the cell cycle S/G2 phase after formation of the initiating cartwheel structure (PubMed:27185865). Required for the recruitment of centriolar proteins, such as POC1B, POC5 and CEP135, into the distal portion of centrioles (PubMed:27185865). Also required for centriole-to-centrosome conversion during mitotic progression, but is dispensable for cartwheel removal or centriole disengagement (PubMed:25131205). Binds to and stabilizes centriolar microtubule (PubMed:27185865). May be involved in ciliogenesis (PubMed:38154379). {ECO:0000269|PubMed:20844083, ECO:0000269|PubMed:25131205, ECO:0000269|PubMed:27185865, ECO:0000269|PubMed:32060285, ECO:0000269|PubMed:38154379}. |
Q9C0D7 | ZC3H12C | S123 | ochoa | Probable ribonuclease ZC3H12C (EC 3.1.-.-) (MCP-induced protein 3) (Zinc finger CCCH domain-containing protein 12C) | May function as RNase and regulate the levels of target RNA species. {ECO:0000305}. |
Q9H165 | BCL11A | S114 | ochoa | BCL11 transcription factor A (B-cell CLL/lymphoma 11A) (B-cell lymphoma/leukemia 11A) (BCL-11A) (COUP-TF-interacting protein 1) (Ecotropic viral integration site 9 protein homolog) (EVI-9) (Zinc finger protein 856) | Transcription factor (PubMed:16704730, PubMed:29606353). Associated with the BAF SWI/SNF chromatin remodeling complex (PubMed:23644491, PubMed:39607926). Binds to the 5'-TGACCA-3' sequence motif in regulatory regions of target genes, including a distal promoter of the HBG1 hemoglobin subunit gamma-1 gene (PubMed:29606353, PubMed:39423807). Involved in regulation of the developmental switch from gamma- to beta-globin, probably via direct repression of HBG1; hence indirectly repressing fetal hemoglobin (HbF) level (PubMed:26375765, PubMed:29606353, PubMed:39423807, PubMed:39607926). Involved in brain development (PubMed:27453576). May play a role in hematopoiesis (By similarity). Essential factor in lymphopoiesis required for B-cell formation in fetal liver (By similarity). May function as a modulator of the transcriptional repression activity of NR2F2 (By similarity). {ECO:0000250|UniProtKB:Q9QYE3, ECO:0000269|PubMed:16704730, ECO:0000269|PubMed:23644491, ECO:0000269|PubMed:29606353, ECO:0000269|PubMed:39423807, ECO:0000269|PubMed:39607926, ECO:0000303|PubMed:26375765, ECO:0000303|PubMed:27453576}. |
Q9H257 | CARD9 | S277 | ochoa | Caspase recruitment domain-containing protein 9 (hCARD9) | Adapter protein that plays a key role in innate immune response against fungi by forming signaling complexes downstream of C-type lectin receptors (PubMed:26961233, PubMed:33558980). CARD9-mediated signals are essential for antifungal immunity against a subset of fungi from the phylum Ascomycota (PubMed:24231284, PubMed:25057046, PubMed:25702837, PubMed:26521038, PubMed:26679537, PubMed:26961233, PubMed:27777981, PubMed:29080677, PubMed:33558980). Transduces signals in myeloid cells downstream of C-type lectin receptors CLEC7A (dectin-1), CLEC6A (dectin-2) and CLEC4E (Mincle), which detect pathogen-associated molecular pattern metabolites (PAMPs), such as fungal carbohydrates, and trigger CARD9 activation (By similarity). Upon activation, CARD9 homooligomerizes to form a nucleating helical template that recruits BCL10 via CARD-CARD interaction, thereby promoting polymerization of BCL10 and subsequent recruitment of MALT1: this leads to activation of NF-kappa-B and MAP kinase p38 (MAPK11, MAPK12, MAPK13 and/or MAPK14) pathways which stimulate expression of genes encoding pro-inflammatory cytokines and chemokines (PubMed:11053425, PubMed:26488816, PubMed:26961233, PubMed:31296852, PubMed:33558980). CARD9 signaling in antigen-presenting cells links innate sensing of fungi to the activation of adaptive immunity and provides a cytokine milieu that induces the development and subsequent of interleukin 17-producing T helper (Th17) cells (PubMed:24231284). Also involved in activation of myeloid cells via classical ITAM-associated receptors and TLR: required for TLR-mediated activation of MAPK, while it is not required for TLR-induced activation of NF-kappa-B (By similarity). CARD9 can also be engaged independently of BCL10: forms a complex with RASGRF1 downstream of C-type lectin receptors, which recruits and activates HRAS, leading to ERK activation and the production of cytokines (By similarity). Acts as an important regulator of the intestinal commensal fungi (mycobiota) component of the gut microbiota (PubMed:33548172). Plays an essential role in antifungal immunity against dissemination of gut fungi: acts by promoting induction of antifungal IgG antibodies response in CX3CR1(+) macrophages to confer protection against disseminated C.albicans or C.auris infection (PubMed:33548172). Also mediates immunity against other pathogens, such as certain bacteria, viruses and parasites; CARD9 signaling is however redundant with other innate immune responses (By similarity). In response to L.monocytogenes infection, required for the production of inflammatory cytokines activated by intracellular peptidoglycan: acts by connecting NOD2 recognition of peptidoglycan to downstream activation of MAP kinases (MAPK) without activating NF-kappa-B (By similarity). {ECO:0000250|UniProtKB:A2AIV8, ECO:0000269|PubMed:11053425, ECO:0000269|PubMed:24231284, ECO:0000269|PubMed:25057046, ECO:0000269|PubMed:25702837, ECO:0000269|PubMed:26488816, ECO:0000269|PubMed:26521038, ECO:0000269|PubMed:26679537, ECO:0000269|PubMed:26961233, ECO:0000269|PubMed:27777981, ECO:0000269|PubMed:29080677, ECO:0000269|PubMed:31296852, ECO:0000269|PubMed:33548172, ECO:0000269|PubMed:33558980}. |
Q9H2Y7 | ZNF106 | S893 | ochoa | Zinc finger protein 106 (Zfp-106) (Zinc finger protein 474) | RNA-binding protein. Specifically binds to 5'-GGGGCC-3' sequence repeats in RNA. Essential for maintenance of peripheral motor neuron and skeletal muscle function. Required for normal expression and/or alternative splicing of a number of genes in spinal cord and skeletal muscle, including the neurite outgrowth inhibitor RTN4. Also contributes to normal mitochondrial respiratory function in motor neurons, via an unknown mechanism. {ECO:0000250|UniProtKB:O88466}. |
Q9H582 | ZNF644 | S1189 | ochoa | Zinc finger protein 644 (Zinc finger motif enhancer-binding protein 2) (Zep-2) | May be involved in transcriptional regulation. |
Q9H694 | BICC1 | S633 | ochoa | Protein bicaudal C homolog 1 (Bic-C) | Putative RNA-binding protein. Acts as a negative regulator of Wnt signaling. May be involved in regulating gene expression during embryonic development. {ECO:0000269|PubMed:21922595}. |
Q9H6S3 | EPS8L2 | Y678 | ochoa | Epidermal growth factor receptor kinase substrate 8-like protein 2 (EPS8-like protein 2) (Epidermal growth factor receptor pathway substrate 8-related protein 2) (EPS8-related protein 2) | Stimulates guanine exchange activity of SOS1. May play a role in membrane ruffling and remodeling of the actin cytoskeleton. In the cochlea, is required for stereocilia maintenance in adult hair cells (By similarity). {ECO:0000250|UniProtKB:Q99K30, ECO:0000269|PubMed:14565974}. |
Q9HCK8 | CHD8 | S2046 | ochoa | Chromodomain-helicase-DNA-binding protein 8 (CHD-8) (EC 3.6.4.-) (ATP-dependent helicase CHD8) (Helicase with SNF2 domain 1) | ATP-dependent chromatin-remodeling factor, it slides nucleosomes along DNA; nucleosome sliding requires ATP (PubMed:28533432). Acts as a transcription repressor by remodeling chromatin structure and recruiting histone H1 to target genes. Suppresses p53/TP53-mediated apoptosis by recruiting histone H1 and preventing p53/TP53 transactivation activity. Acts as a negative regulator of Wnt signaling pathway by regulating beta-catenin (CTNNB1) activity. Negatively regulates CTNNB1-targeted gene expression by being recruited specifically to the promoter regions of several CTNNB1 responsive genes. Involved in both enhancer blocking and epigenetic remodeling at chromatin boundary via its interaction with CTCF. Acts as a suppressor of STAT3 activity by suppressing the LIF-induced STAT3 transcriptional activity. Also acts as a transcription activator via its interaction with ZNF143 by participating in efficient U6 RNA polymerase III transcription. Regulates alternative splicing of a core group of genes involved in neuronal differentiation, cell cycle and DNA repair. Enables H3K36me3-coupled transcription elongation and co-transcriptional RNA processing likely via interaction with HNRNPL. {ECO:0000255|HAMAP-Rule:MF_03071, ECO:0000269|PubMed:17938208, ECO:0000269|PubMed:18378692, ECO:0000269|PubMed:28533432, ECO:0000269|PubMed:36537238}. |
Q9NQC3 | RTN4 | S739 | ochoa | Reticulon-4 (Foocen) (Neurite outgrowth inhibitor) (Nogo protein) (Neuroendocrine-specific protein) (NSP) (Neuroendocrine-specific protein C homolog) (RTN-x) (Reticulon-5) | Required to induce the formation and stabilization of endoplasmic reticulum (ER) tubules (PubMed:24262037, PubMed:25612671, PubMed:27619977). They regulate membrane morphogenesis in the ER by promoting tubular ER production (PubMed:24262037, PubMed:25612671, PubMed:27619977, PubMed:27786289). They influence nuclear envelope expansion, nuclear pore complex formation and proper localization of inner nuclear membrane proteins (PubMed:26906412). However each isoform have specific functions mainly depending on their tissue expression specificities (Probable). {ECO:0000269|PubMed:24262037, ECO:0000269|PubMed:25612671, ECO:0000269|PubMed:26906412, ECO:0000269|PubMed:27619977, ECO:0000269|PubMed:27786289, ECO:0000305}.; FUNCTION: [Isoform A]: Developmental neurite growth regulatory factor with a role as a negative regulator of axon-axon adhesion and growth, and as a facilitator of neurite branching. Regulates neurite fasciculation, branching and extension in the developing nervous system. Involved in down-regulation of growth, stabilization of wiring and restriction of plasticity in the adult CNS (PubMed:10667797, PubMed:11201742). Regulates the radial migration of cortical neurons via an RTN4R-LINGO1 containing receptor complex (By similarity). Acts as a negative regulator of central nervous system angiogenesis. Inhibits spreading, migration and sprouting of primary brain microvascular endothelial cells (MVECs). Also induces the retraction of MVECs lamellipodia and filopodia in a ROCK pathway-dependent manner (By similarity). {ECO:0000250|UniProtKB:Q99P72, ECO:0000269|PubMed:10667797, ECO:0000269|PubMed:11201742, ECO:0000269|PubMed:19699797}.; FUNCTION: [Isoform B]: Mainly function in endothelial cells and vascular smooth muscle cells, is also involved in immune system regulation (Probable). Modulator of vascular remodeling, promotes the migration of endothelial cells but inhibits the migration of vascular smooth muscle cells. Regulates endothelial sphingolipid biosynthesis with direct effects on vascular function and blood pressure. Inhibits serine palmitoyltransferase, SPTLC1, the rate-limiting enzyme of the novo sphingolipid biosynthetic pathway, thereby controlling production of endothelial sphingosine-1-phosphate (S1P). Required to promote macrophage homing and functions such as cytokine/chemokine gene expression involved in angiogenesis, arteriogenesis and tissue repair. Mediates ICAM1 induced transendothelial migration of leukocytes such as monocytes and neutrophils and acute inflammation. Necessary for immune responses triggered by nucleic acid sensing TLRs, such as TLR9, is required for proper TLR9 location to endolysosomes. Also involved in immune response to LPS. Plays a role in liver regeneration through the modulation of hepatocytes proliferation (By similarity). Reduces the anti-apoptotic activity of Bcl-xl and Bcl-2. This is likely consecutive to their change in subcellular location, from the mitochondria to the endoplasmic reticulum, after binding and sequestration (PubMed:11126360). With isoform C, inhibits BACE1 activity and amyloid precursor protein processing (PubMed:16965550). {ECO:0000250|UniProtKB:Q99P72, ECO:0000269|PubMed:11126360, ECO:0000269|PubMed:16965550, ECO:0000305}.; FUNCTION: [Isoform C]: Regulates cardiomyocyte apoptosis upon hypoxic conditions (By similarity). With isoform B, inhibits BACE1 activity and amyloid precursor protein processing (PubMed:16965550). {ECO:0000250|UniProtKB:Q99P72, ECO:0000269|PubMed:16965550}. |
Q9NRR4 | DROSHA | S355 | ochoa|psp | Ribonuclease 3 (EC 3.1.26.3) (Protein Drosha) (Ribonuclease III) (RNase III) (p241) | Ribonuclease III double-stranded (ds) RNA-specific endoribonuclease that is involved in the initial step of microRNA (miRNA) biogenesis. Component of the microprocessor complex that is required to process primary miRNA transcripts (pri-miRNAs) to release precursor miRNA (pre-miRNA) in the nucleus. Within the microprocessor complex, DROSHA cleaves the 3' and 5' strands of a stem-loop in pri-miRNAs (processing center 11 bp from the dsRNA-ssRNA junction) to release hairpin-shaped pre-miRNAs that are subsequently cut by the cytoplasmic DICER to generate mature miRNAs. Involved also in pre-rRNA processing. Cleaves double-strand RNA and does not cleave single-strand RNA. Involved in the formation of GW bodies. Plays a role in growth homeostasis in response to autophagy in motor neurons (By similarity). {ECO:0000250|UniProtKB:Q5HZJ0, ECO:0000269|PubMed:10948199, ECO:0000269|PubMed:14508493, ECO:0000269|PubMed:15531877, ECO:0000269|PubMed:15565168, ECO:0000269|PubMed:15574589, ECO:0000269|PubMed:15589161, ECO:0000269|PubMed:16751099, ECO:0000269|PubMed:16906129, ECO:0000269|PubMed:17159994, ECO:0000269|PubMed:26027739, ECO:0000269|PubMed:26748718}. |
Q9NS25 | SPANXB1 | S69 | ochoa | Sperm protein associated with the nucleus on the X chromosome B1 (Cancer/testis antigen 11.2) (CT11.2) (Nuclear-associated protein SPAN-Xb) (SPANX-B) (SPANX family member B1) (SPANX family member F1) | None |
Q9NS26 | SPANXA1 | S63 | ochoa | Sperm protein associated with the nucleus on the X chromosome A (Cancer/testis antigen 11.1) (CT11.1) (Nuclear-associated protein SPAN-Xa) (SPAN-X) (SPANX-A) (SPANX family member A) | None |
Q9NXH9 | TRMT1 | S517 | ochoa | tRNA (guanine(26)-N(2))-dimethyltransferase (EC 2.1.1.216) (tRNA 2,2-dimethylguanosine-26 methyltransferase) (tRNA methyltransferase 1) (hTRM1) (tRNA(guanine-26,N(2)-N(2)) methyltransferase) (tRNA(m(2,2)G26)dimethyltransferase) | Dimethylates a single guanine residue at position 26 of most nuclear- and mitochondrial-encoded tRNAs using S-adenosyl-L-methionine as donor of the methyl groups (PubMed:10982862, PubMed:28784718, PubMed:37204604, PubMed:39786990). tRNA guanine(26)-dimethylation is required for redox homeostasis and ensure proper cellular proliferation and oxidative stress survival (PubMed:28784718). {ECO:0000269|PubMed:10982862, ECO:0000269|PubMed:28784718, ECO:0000269|PubMed:37204604, ECO:0000269|PubMed:39786990}. |
Q9NYW8 | RBAK | S78 | ochoa | RB-associated KRAB zinc finger protein (RB-associated KRAB repressor) (hRBaK) (Zinc finger protein 769) | May repress E2F-dependent transcription. May promote AR-dependent transcription. {ECO:0000269|PubMed:10702291, ECO:0000269|PubMed:14664718}. |
Q9NZ56 | FMN2 | S361 | ochoa | Formin-2 | Actin-binding protein that is involved in actin cytoskeleton assembly and reorganization (PubMed:21730168, PubMed:22330775). Acts as an actin nucleation factor and promotes assembly of actin filaments together with SPIRE1 and SPIRE2 (PubMed:21730168, PubMed:22330775). Involved in intracellular vesicle transport along actin fibers, providing a novel link between actin cytoskeleton dynamics and intracellular transport (By similarity). Required for asymmetric spindle positioning, asymmetric oocyte division and polar body extrusion during female germ cell meiosis (By similarity). Plays a role in responses to DNA damage, cellular stress and hypoxia by protecting CDKN1A against degradation, and thereby plays a role in stress-induced cell cycle arrest (PubMed:23375502). Also acts in the nucleus: together with SPIRE1 and SPIRE2, promotes assembly of nuclear actin filaments in response to DNA damage in order to facilitate movement of chromatin and repair factors after DNA damage (PubMed:26287480). Protects cells against apoptosis by protecting CDKN1A against degradation (PubMed:23375502). {ECO:0000250|UniProtKB:Q9JL04, ECO:0000269|PubMed:21730168, ECO:0000269|PubMed:22330775, ECO:0000269|PubMed:23375502, ECO:0000269|PubMed:26287480}. |
Q9P0N8 | MARCHF2 | S223 | ochoa | E3 ubiquitin-protein ligase MARCHF2 (EC 2.3.2.27) (Membrane-associated RING finger protein 2) (Membrane-associated RING-CH protein II) (MARCH-II) (RING finger protein 172) (RING-type E3 ubiquitin transferase MARCHF2) | E3 ubiquitin-protein ligase that may mediate ubiquitination of TFRC and CD86, and promote their subsequent endocytosis and sorting to lysosomes via multivesicular bodies. E3 ubiquitin ligases accept ubiquitin from an E2 ubiquitin-conjugating enzyme in the form of a thioester and then directly transfer the ubiquitin to targeted substrates (PubMed:14722266, PubMed:16428329). Together with GOPC/CAL mediates the ubiquitination and lysosomal degradation of CFTR (PubMed:23818989). Ubiquitinates and therefore mediates the degradation of DLG1 (PubMed:17980554). Regulates the intracellular trafficking and secretion of alpha1-antitrypsin/SERPINA1 and HP/haptoglobin via ubiquitination and degradation of the cargo receptor ERGIC3 (PubMed:31142615). Negatively regulates the antiviral and antibacterial immune response by repression of the NF-kB and type 1 IFN signaling pathways, via MARCHF2-mediated K48-linked polyubiquitination of IKBKG/NEMO, resulting in its proteasomal degradation (PubMed:32935379). May be involved in endosomal trafficking through interaction with STX6 (PubMed:15689499). {ECO:0000269|PubMed:14722266, ECO:0000269|PubMed:15689499, ECO:0000269|PubMed:16428329, ECO:0000269|PubMed:17980554, ECO:0000269|PubMed:23818989, ECO:0000269|PubMed:31142615, ECO:0000269|PubMed:32935379}.; FUNCTION: (Microbial infection) Positively regulates the degradation of Vesicular stomatitis virus (VSV) G protein via the lysosomal degradation pathway (PubMed:29573664). Represses HIV-1 viral production and may inhibit the translocation of HIV-1 env to the cell surface, resulting in decreased viral cell-cell transmission (PubMed:29573664). {ECO:0000269|PubMed:29573664}. |
Q9UHN1 | POLG2 | S38 | ochoa | DNA polymerase subunit gamma-2 (DNA polymerase gamma accessory 55 kDa subunit) (p55) (Mitochondrial DNA polymerase accessory subunit) (MtPolB) (PolG-beta) | Accessory subunit of DNA polymerase gamma solely responsible for replication of mitochondrial DNA (mtDNA). Acts as an allosteric regulator of the holoenzyme activities. Enhances the polymerase activity and the processivity of POLG by increasing its interactions with the DNA template. Suppresses POLG exonucleolytic proofreading especially toward homopolymeric templates bearing mismatched termini. Binds to single-stranded DNA. {ECO:0000269|PubMed:11477093, ECO:0000269|PubMed:11477094, ECO:0000269|PubMed:11504725, ECO:0000269|PubMed:15167897, ECO:0000269|PubMed:19837034, ECO:0000269|PubMed:26056153, ECO:0000269|PubMed:30157269, ECO:0000269|PubMed:31778857, ECO:0000269|PubMed:37202477}. |
Q9UNZ2 | NSFL1C | S177 | ochoa | NSFL1 cofactor p47 (UBX domain-containing protein 2C) (p97 cofactor p47) | Reduces the ATPase activity of VCP (By similarity). Necessary for the fragmentation of Golgi stacks during mitosis and for VCP-mediated reassembly of Golgi stacks after mitosis (By similarity). May play a role in VCP-mediated formation of transitional endoplasmic reticulum (tER) (By similarity). Inhibits the activity of CTSL (in vitro) (PubMed:15498563). Together with UBXN2B/p37, regulates the centrosomal levels of kinase AURKA/Aurora A during mitotic progression by promoting AURKA removal from centrosomes in prophase (PubMed:23649807). Also, regulates spindle orientation during mitosis (PubMed:23649807). {ECO:0000250|UniProtKB:O35987, ECO:0000269|PubMed:15498563, ECO:0000269|PubMed:23649807}. |
Q9UPV0 | CEP164 | S472 | ochoa | Centrosomal protein of 164 kDa (Cep164) | Plays a role in microtubule organization and/or maintenance for the formation of primary cilia (PC), a microtubule-based structure that protrudes from the surface of epithelial cells. Plays a critical role in G2/M checkpoint and nuclear divisions. A key player in the DNA damage-activated ATR/ATM signaling cascade since it is required for the proper phosphorylation of H2AX, RPA, CHEK2 and CHEK1. Plays a critical role in chromosome segregation, acting as a mediator required for the maintenance of genomic stability through modulation of MDC1, RPA and CHEK1. {ECO:0000269|PubMed:17954613, ECO:0000269|PubMed:18283122, ECO:0000269|PubMed:23348840}. |
Q9UPV9 | TRAK1 | S393 | ochoa | Trafficking kinesin-binding protein 1 (106 kDa O-GlcNAc transferase-interacting protein) (Protein Milton) | Involved in the regulation of endosome-to-lysosome trafficking, including endocytic trafficking of EGF-EGFR complexes and GABA-A receptors (PubMed:18675823). Involved in mitochondrial motility. When O-glycosylated, abolishes mitochondrial motility. Crucial for recruiting OGT to the mitochondrial surface of neuronal processes (PubMed:24995978). TRAK1 and RHOT form an essential protein complex that links KIF5 to mitochondria for light chain-independent, anterograde transport of mitochondria (By similarity). {ECO:0000250|UniProtKB:Q960V3, ECO:0000269|PubMed:18675823, ECO:0000269|PubMed:24995978}. |
Q9Y250 | LZTS1 | S254 | ochoa | Leucine zipper putative tumor suppressor 1 (F37/esophageal cancer-related gene-coding leucine-zipper motif) (Fez1) | Involved in the regulation of cell growth. May stabilize the active CDC2-cyclin B1 complex and thereby contribute to the regulation of the cell cycle and the prevention of uncontrolled cell proliferation. May act as a tumor suppressor. {ECO:0000269|PubMed:10097140, ECO:0000269|PubMed:11464283, ECO:0000269|PubMed:11504921}. |
Q9Y520 | PRRC2C | S2143 | ochoa | Protein PRRC2C (BAT2 domain-containing protein 1) (HBV X-transactivated gene 2 protein) (HBV XAg-transactivated protein 2) (HLA-B-associated transcript 2-like 2) (Proline-rich and coiled-coil-containing protein 2C) | Required for efficient formation of stress granules. {ECO:0000269|PubMed:29395067}. |
V9GYD0 | ARL2-SNX15 | S45 | ochoa | ARL2-SNX15 readthrough (NMD candidate) | None |
P13798 | APEH | S97 | Sugiyama | Acylamino-acid-releasing enzyme (AARE) (EC 3.4.19.1) (Acyl-peptide hydrolase) (APH) (Acylaminoacyl-peptidase) (Oxidized protein hydrolase) (OPH) | This enzyme catalyzes the hydrolysis of the N-terminal peptide bond of an N-acetylated peptide to generate an N-acetylated amino acid and a peptide with a free N-terminus (PubMed:10719179, PubMed:1740429, PubMed:2006156). It preferentially cleaves off Ac-Ala, Ac-Met and Ac-Ser (By similarity). Also, involved in the degradation of oxidized and glycated proteins (PubMed:10719179). {ECO:0000250|UniProtKB:P13676, ECO:0000269|PubMed:10719179, ECO:0000269|PubMed:1740429, ECO:0000269|PubMed:2006156}. |
Q12824 | SMARCB1 | S111 | Sugiyama | SWI/SNF-related matrix-associated actin-dependent regulator of chromatin subfamily B member 1 (BRG1-associated factor 47) (BAF47) (Integrase interactor 1 protein) (SNF5 homolog) (hSNF5) | Core component of the BAF (hSWI/SNF) complex. This ATP-dependent chromatin-remodeling complex plays important roles in cell proliferation and differentiation, in cellular antiviral activities and inhibition of tumor formation. The BAF complex is able to create a stable, altered form of chromatin that constrains fewer negative supercoils than normal. This change in supercoiling would be due to the conversion of up to one-half of the nucleosomes on polynucleosomal arrays into asymmetric structures, termed altosomes, each composed of 2 histones octamers. Stimulates in vitro the remodeling activity of SMARCA4/BRG1/BAF190A. Involved in activation of CSF1 promoter. Belongs to the neural progenitors-specific chromatin remodeling complex (npBAF complex) and the neuron-specific chromatin remodeling complex (nBAF complex). During neural development a switch from a stem/progenitor to a postmitotic chromatin remodeling mechanism occurs as neurons exit the cell cycle and become committed to their adult state. The transition from proliferating neural stem/progenitor cells to postmitotic neurons requires a switch in subunit composition of the npBAF and nBAF complexes. As neural progenitors exit mitosis and differentiate into neurons, npBAF complexes which contain ACTL6A/BAF53A and PHF10/BAF45A, are exchanged for homologous alternative ACTL6B/BAF53B and DPF1/BAF45B or DPF3/BAF45C subunits in neuron-specific complexes (nBAF). The npBAF complex is essential for the self-renewal/proliferative capacity of the multipotent neural stem cells. The nBAF complex along with CREST plays a role regulating the activity of genes essential for dendrite growth (By similarity). Plays a key role in cell-cycle control and causes cell cycle arrest in G0/G1. {ECO:0000250|UniProtKB:Q9Z0H3, ECO:0000269|PubMed:10078207, ECO:0000269|PubMed:12226744, ECO:0000269|PubMed:14604992, ECO:0000269|PubMed:16267391, ECO:0000269|PubMed:16314535, ECO:0000269|PubMed:9448295}. |
P09132 | SRP19 | S69 | Sugiyama | Signal recognition particle 19 kDa protein (SRP19) | Component of the signal recognition particle (SRP) complex, a ribonucleoprotein complex that mediates the cotranslational targeting of secretory and membrane proteins to the endoplasmic reticulum (ER) (By similarity). Binds directly to 7SL RNA (By similarity). Mediates binding of SRP54 to the SRP complex (By similarity). {ECO:0000250|UniProtKB:J9PAS6}. |
Q8NE63 | HIPK4 | S337 | Sugiyama | Homeodomain-interacting protein kinase 4 (EC 2.7.11.1) | Protein kinase that phosphorylates human TP53 at Ser-9, and thus induces TP53 repression of BIRC5 promoter (By similarity). May act as a corepressor of transcription factors (Potential). {ECO:0000250, ECO:0000305}. |
Download
reactome_id | name | p | -log10_p |
---|---|---|---|
R-HSA-9933946 | Formation of the embryonic stem cell BAF (esBAF) complex | 0.000386 | 3.413 |
R-HSA-9934037 | Formation of neuronal progenitor and neuronal BAF (npBAF and nBAF) | 0.000853 | 3.069 |
R-HSA-9932451 | SWI/SNF chromatin remodelers | 0.001575 | 2.803 |
R-HSA-9932444 | ATP-dependent chromatin remodelers | 0.001575 | 2.803 |
R-HSA-9818749 | Regulation of NFE2L2 gene expression | 0.002031 | 2.692 |
R-HSA-1640170 | Cell Cycle | 0.002542 | 2.595 |
R-HSA-9006821 | Alternative Lengthening of Telomeres (ALT) | 0.014427 | 1.841 |
R-HSA-9673013 | Diseases of Telomere Maintenance | 0.014427 | 1.841 |
R-HSA-9670621 | Defective Inhibition of DNA Recombination at Telomere | 0.014427 | 1.841 |
R-HSA-211728 | Regulation of PAK-2p34 activity by PS-GAP/RHG10 | 0.014427 | 1.841 |
R-HSA-9670613 | Defective Inhibition of DNA Recombination at Telomere Due to DAXX Mutations | 0.014427 | 1.841 |
R-HSA-9709275 | Impaired BRCA2 translocation to the nucleus | 0.014427 | 1.841 |
R-HSA-9763198 | Impaired BRCA2 binding to SEM1 (DSS1) | 0.014427 | 1.841 |
R-HSA-9670615 | Defective Inhibition of DNA Recombination at Telomere Due to ATRX Mutations | 0.014427 | 1.841 |
R-HSA-5685939 | HDR through MMEJ (alt-NHEJ) | 0.006978 | 2.156 |
R-HSA-9709603 | Impaired BRCA2 binding to PALB2 | 0.013456 | 1.871 |
R-HSA-9701193 | Defective homologous recombination repair (HRR) due to PALB2 loss of function | 0.014533 | 1.838 |
R-HSA-9704646 | Defective HDR through Homologous Recombination Repair (HRR) due to PALB2 loss of... | 0.014533 | 1.838 |
R-HSA-9704331 | Defective HDR through Homologous Recombination Repair (HRR) due to PALB2 loss of... | 0.014533 | 1.838 |
R-HSA-9701192 | Defective homologous recombination repair (HRR) due to BRCA1 loss of function | 0.014533 | 1.838 |
R-HSA-9933939 | Formation of the polybromo-BAF (pBAF) complex | 0.007786 | 2.109 |
R-HSA-9933937 | Formation of the canonical BAF (cBAF) complex | 0.007786 | 2.109 |
R-HSA-5696398 | Nucleotide Excision Repair | 0.010794 | 1.967 |
R-HSA-9823739 | Formation of the anterior neural plate | 0.008634 | 2.064 |
R-HSA-73894 | DNA Repair | 0.006759 | 2.170 |
R-HSA-177929 | Signaling by EGFR | 0.011666 | 1.933 |
R-HSA-1852241 | Organelle biogenesis and maintenance | 0.012391 | 1.907 |
R-HSA-211736 | Stimulation of the cell death response by PAK-2p34 | 0.028648 | 1.543 |
R-HSA-9818035 | NFE2L2 regulating ER-stress associated genes | 0.042666 | 1.370 |
R-HSA-69200 | Phosphorylation of proteins involved in G1/S transition by active Cyclin E:Cdk2 ... | 0.042666 | 1.370 |
R-HSA-9818025 | NFE2L2 regulating TCA cycle genes | 0.049599 | 1.305 |
R-HSA-9818026 | NFE2L2 regulating inflammation associated genes | 0.049599 | 1.305 |
R-HSA-9022537 | Loss of MECP2 binding ability to the NCoR/SMRT complex | 0.056482 | 1.248 |
R-HSA-9818032 | NFE2L2 regulating MDR associated enzymes | 0.083526 | 1.078 |
R-HSA-9700645 | ALK mutants bind TKIs | 0.083526 | 1.078 |
R-HSA-9818028 | NFE2L2 regulates pentose phosphate pathway genes | 0.103302 | 0.986 |
R-HSA-5693554 | Resolution of D-loop Structures through Synthesis-Dependent Strand Annealing (SD... | 0.021726 | 1.663 |
R-HSA-9661069 | Defective binding of RB1 mutants to E2F1,(E2F2, E2F3) | 0.116251 | 0.935 |
R-HSA-9709570 | Impaired BRCA2 binding to RAD51 | 0.027181 | 1.566 |
R-HSA-5696394 | DNA Damage Recognition in GG-NER | 0.034684 | 1.460 |
R-HSA-9701190 | Defective homologous recombination repair (HRR) due to BRCA2 loss of function | 0.036271 | 1.440 |
R-HSA-9670095 | Inhibition of DNA recombination at telomere | 0.046355 | 1.334 |
R-HSA-167242 | Abortive elongation of HIV-1 transcript in the absence of Tat | 0.160129 | 0.796 |
R-HSA-6781823 | Formation of TC-NER Pre-Incision Complex | 0.059241 | 1.227 |
R-HSA-5693571 | Nonhomologous End-Joining (NHEJ) | 0.063126 | 1.200 |
R-HSA-6803529 | FGFR2 alternative splicing | 0.184226 | 0.735 |
R-HSA-77075 | RNA Pol II CTD phosphorylation and interaction with CE | 0.190142 | 0.721 |
R-HSA-167160 | RNA Pol II CTD phosphorylation and interaction with CE during HIV infection | 0.190142 | 0.721 |
R-HSA-6782210 | Gap-filling DNA repair synthesis and ligation in TC-NER | 0.079472 | 1.100 |
R-HSA-6782135 | Dual incision in TC-NER | 0.083745 | 1.077 |
R-HSA-445095 | Interaction between L1 and Ankyrins | 0.213384 | 0.671 |
R-HSA-167243 | Tat-mediated HIV elongation arrest and recovery | 0.213384 | 0.671 |
R-HSA-167238 | Pausing and recovery of Tat-mediated HIV elongation | 0.213384 | 0.671 |
R-HSA-9845323 | Regulation of endogenous retroelements by Piwi-interacting RNAs (piRNAs) | 0.088087 | 1.055 |
R-HSA-167158 | Formation of the HIV-1 Early Elongation Complex | 0.219090 | 0.659 |
R-HSA-167287 | HIV elongation arrest and recovery | 0.219090 | 0.659 |
R-HSA-113418 | Formation of the Early Elongation Complex | 0.219090 | 0.659 |
R-HSA-167290 | Pausing and recovery of HIV elongation | 0.219090 | 0.659 |
R-HSA-380284 | Loss of proteins required for interphase microtubule organization from the centr... | 0.094723 | 1.024 |
R-HSA-380259 | Loss of Nlp from mitotic centrosomes | 0.094723 | 1.024 |
R-HSA-5619107 | Defective TPR may confer susceptibility towards thyroid papillary carcinoma (TPC... | 0.230380 | 0.638 |
R-HSA-8854518 | AURKA Activation by TPX2 | 0.101497 | 0.994 |
R-HSA-1855196 | IP3 and IP4 transport between cytosol and nucleus | 0.235965 | 0.627 |
R-HSA-211733 | Regulation of activated PAK-2p34 by proteasome mediated degradation | 0.235965 | 0.627 |
R-HSA-1855229 | IP6 and IP7 transport between cytosol and nucleus | 0.235965 | 0.627 |
R-HSA-1855170 | IPs transport between nucleus and cytosol | 0.247013 | 0.607 |
R-HSA-159227 | Transport of the SLBP independent Mature mRNA | 0.247013 | 0.607 |
R-HSA-159230 | Transport of the SLBP Dependant Mature mRNA | 0.252477 | 0.598 |
R-HSA-380270 | Recruitment of mitotic centrosome proteins and complexes | 0.117797 | 0.929 |
R-HSA-6781827 | Transcription-Coupled Nucleotide Excision Repair (TC-NER) | 0.122568 | 0.912 |
R-HSA-380287 | Centrosome maturation | 0.122568 | 0.912 |
R-HSA-3301854 | Nuclear Pore Complex (NPC) Disassembly | 0.263289 | 0.580 |
R-HSA-9762114 | GSK3B and BTRC:CUL1-mediated-degradation of NFE2L2 | 0.273945 | 0.562 |
R-HSA-159231 | Transport of Mature mRNA Derived from an Intronless Transcript | 0.284449 | 0.546 |
R-HSA-159234 | Transport of Mature mRNAs Derived from Intronless Transcripts | 0.289644 | 0.538 |
R-HSA-167152 | Formation of HIV elongation complex in the absence of HIV Tat | 0.289644 | 0.538 |
R-HSA-380320 | Recruitment of NuMA to mitotic centrosomes | 0.157154 | 0.804 |
R-HSA-9759194 | Nuclear events mediated by NFE2L2 | 0.257173 | 0.590 |
R-HSA-5693607 | Processing of DNA double-strand break ends | 0.137155 | 0.863 |
R-HSA-167169 | HIV Transcription Elongation | 0.289644 | 0.538 |
R-HSA-9818027 | NFE2L2 regulating anti-oxidant/detoxification enzymes | 0.252477 | 0.598 |
R-HSA-9818030 | NFE2L2 regulating tumorigenic genes | 0.116251 | 0.935 |
R-HSA-72086 | mRNA Capping | 0.224756 | 0.648 |
R-HSA-5620912 | Anchoring of the basal body to the plasma membrane | 0.162238 | 0.790 |
R-HSA-167246 | Tat-mediated elongation of the HIV-1 transcript | 0.289644 | 0.538 |
R-HSA-169911 | Regulation of Apoptosis | 0.263289 | 0.580 |
R-HSA-5693538 | Homology Directed Repair | 0.072172 | 1.142 |
R-HSA-167200 | Formation of HIV-1 elongation complex containing HIV-1 Tat | 0.284449 | 0.546 |
R-HSA-9675136 | Diseases of DNA Double-Strand Break Repair | 0.036271 | 1.440 |
R-HSA-749476 | RNA Polymerase III Abortive And Retractive Initiation | 0.039527 | 1.403 |
R-HSA-5693567 | HDR through Homologous Recombination (HRR) or Single Strand Annealing (SSA) | 0.064714 | 1.189 |
R-HSA-2465910 | MASTL Facilitates Mitotic Progression | 0.083526 | 1.078 |
R-HSA-76066 | RNA Polymerase III Transcription Initiation From Type 2 Promoter | 0.178267 | 0.749 |
R-HSA-76071 | RNA Polymerase III Transcription Initiation From Type 3 Promoter | 0.184226 | 0.735 |
R-HSA-5693616 | Presynaptic phase of homologous DNA pairing and strand exchange | 0.037886 | 1.422 |
R-HSA-5693579 | Homologous DNA Pairing and Strand Exchange | 0.042889 | 1.368 |
R-HSA-9931509 | Expression of BMAL (ARNTL), CLOCK, and NPAS2 | 0.284449 | 0.546 |
R-HSA-76046 | RNA Polymerase III Transcription Initiation | 0.230380 | 0.638 |
R-HSA-9860276 | SLC15A4:TASL-dependent IRF5 activation | 0.056482 | 1.248 |
R-HSA-5685942 | HDR through Homologous Recombination (HRR) | 0.103785 | 0.984 |
R-HSA-5685938 | HDR through Single Strand Annealing (SSA) | 0.247013 | 0.607 |
R-HSA-74158 | RNA Polymerase III Transcription | 0.039527 | 1.403 |
R-HSA-5617472 | Activation of anterior HOX genes in hindbrain development during early embryogen... | 0.206469 | 0.685 |
R-HSA-5619507 | Activation of HOX genes during differentiation | 0.206469 | 0.685 |
R-HSA-5693537 | Resolution of D-Loop Structures | 0.034684 | 1.460 |
R-HSA-9675126 | Diseases of mitotic cell cycle | 0.031596 | 1.500 |
R-HSA-76061 | RNA Polymerase III Transcription Initiation From Type 1 Promoter | 0.184226 | 0.735 |
R-HSA-912446 | Meiotic recombination | 0.069109 | 1.160 |
R-HSA-5696395 | Formation of Incision Complex in GG-NER | 0.289644 | 0.538 |
R-HSA-73779 | RNA Polymerase II Transcription Pre-Initiation And Promoter Opening | 0.289644 | 0.538 |
R-HSA-5693568 | Resolution of D-loop Structures through Holliday Junction Intermediates | 0.033126 | 1.480 |
R-HSA-9820841 | M-decay: degradation of maternal mRNAs by maternally stored factors | 0.294801 | 0.530 |
R-HSA-5693532 | DNA Double-Strand Break Repair | 0.036702 | 1.435 |
R-HSA-5696399 | Global Genome Nucleotide Excision Repair (GG-NER) | 0.144587 | 0.840 |
R-HSA-9913635 | Strand-asynchronous mitochondrial DNA replication | 0.160129 | 0.796 |
R-HSA-2470946 | Cohesin Loading onto Chromatin | 0.070101 | 1.154 |
R-HSA-193634 | Axonal growth inhibition (RHOA activation) | 0.076838 | 1.114 |
R-HSA-428543 | Inactivation of CDC42 and RAC1 | 0.083526 | 1.078 |
R-HSA-9659787 | Aberrant regulation of mitotic G1/S transition in cancer due to RB1 defects | 0.116251 | 0.935 |
R-HSA-9933947 | Formation of the non-canonical BAF (ncBAF) complex | 0.116251 | 0.935 |
R-HSA-399954 | Sema3A PAK dependent Axon repulsion | 0.129015 | 0.889 |
R-HSA-73980 | RNA Polymerase III Transcription Termination | 0.153996 | 0.812 |
R-HSA-8851708 | Signaling by FGFR2 IIIa TM | 0.160129 | 0.796 |
R-HSA-350054 | Notch-HLH transcription pathway | 0.184226 | 0.735 |
R-HSA-168325 | Viral Messenger RNA Synthesis | 0.090283 | 1.044 |
R-HSA-390471 | Association of TriC/CCT with target proteins during biosynthesis | 0.252477 | 0.598 |
R-HSA-180910 | Vpr-mediated nuclear import of PICs | 0.273945 | 0.562 |
R-HSA-9933387 | RORA,B,C and NR1D1 (REV-ERBA) regulate gene expression | 0.230380 | 0.638 |
R-HSA-9707616 | Heme signaling | 0.092495 | 1.034 |
R-HSA-447043 | Neurofascin interactions | 0.063316 | 1.198 |
R-HSA-1660517 | Synthesis of PIPs at the late endosome membrane | 0.147818 | 0.830 |
R-HSA-3295583 | TRP channels | 0.207636 | 0.683 |
R-HSA-5620922 | BBSome-mediated cargo-targeting to cilium | 0.166219 | 0.779 |
R-HSA-5578749 | Transcriptional regulation by small RNAs | 0.115429 | 0.938 |
R-HSA-170822 | Regulation of Glucokinase by Glucokinase Regulatory Protein | 0.252477 | 0.598 |
R-HSA-5213460 | RIPK1-mediated regulated necrosis | 0.279216 | 0.554 |
R-HSA-193697 | p75NTR regulates axonogenesis | 0.083526 | 1.078 |
R-HSA-1500620 | Meiosis | 0.147083 | 0.832 |
R-HSA-9832991 | Formation of the posterior neural plate | 0.096758 | 1.014 |
R-HSA-1483226 | Synthesis of PI | 0.096758 | 1.014 |
R-HSA-9623433 | NR1H2 & NR1H3 regulate gene expression to control bile acid homeostasis | 0.103302 | 0.986 |
R-HSA-77387 | Insulin receptor recycling | 0.219090 | 0.659 |
R-HSA-9687139 | Aberrant regulation of mitotic cell cycle due to RB1 defects | 0.230380 | 0.638 |
R-HSA-5675482 | Regulation of necroptotic cell death | 0.247013 | 0.607 |
R-HSA-2565942 | Regulation of PLK1 Activity at G2/M Transition | 0.144587 | 0.840 |
R-HSA-162906 | HIV Infection | 0.267510 | 0.573 |
R-HSA-68877 | Mitotic Prometaphase | 0.200562 | 0.698 |
R-HSA-182971 | EGFR downregulation | 0.030095 | 1.522 |
R-HSA-6794361 | Neurexins and neuroligins | 0.071143 | 1.148 |
R-HSA-180746 | Nuclear import of Rev protein | 0.257903 | 0.589 |
R-HSA-3928664 | Ephrin signaling | 0.153996 | 0.812 |
R-HSA-5218920 | VEGFR2 mediated vascular permeability | 0.294801 | 0.530 |
R-HSA-9707587 | Regulation of HMOX1 expression and activity | 0.042666 | 1.370 |
R-HSA-447038 | NrCAM interactions | 0.049599 | 1.305 |
R-HSA-8948747 | Regulation of PTEN localization | 0.070101 | 1.154 |
R-HSA-68884 | Mitotic Telophase/Cytokinesis | 0.103302 | 0.986 |
R-HSA-428540 | Activation of RAC1 | 0.103302 | 0.986 |
R-HSA-203927 | MicroRNA (miRNA) biogenesis | 0.021726 | 1.663 |
R-HSA-429947 | Deadenylation of mRNA | 0.196015 | 0.708 |
R-HSA-83936 | Transport of nucleosides and free purine and pyrimidine bases across the plasma ... | 0.213384 | 0.671 |
R-HSA-69473 | G2/M DNA damage checkpoint | 0.120177 | 0.920 |
R-HSA-177243 | Interactions of Rev with host cellular proteins | 0.289644 | 0.538 |
R-HSA-176033 | Interactions of Vpr with host cellular proteins | 0.289644 | 0.538 |
R-HSA-168271 | Transport of Ribonucleoproteins into the Host Nucleus | 0.294801 | 0.530 |
R-HSA-5617833 | Cilium Assembly | 0.066750 | 1.176 |
R-HSA-9686347 | Microbial modulation of RIPK1-mediated regulated necrosis | 0.070101 | 1.154 |
R-HSA-4839726 | Chromatin organization | 0.047157 | 1.326 |
R-HSA-73886 | Chromosome Maintenance | 0.076041 | 1.119 |
R-HSA-9675135 | Diseases of DNA repair | 0.059241 | 1.227 |
R-HSA-164944 | Nef and signal transduction | 0.063316 | 1.198 |
R-HSA-447041 | CHL1 interactions | 0.070101 | 1.154 |
R-HSA-9693928 | Defective RIPK1-mediated regulated necrosis | 0.090166 | 1.045 |
R-HSA-9005895 | Pervasive developmental disorders | 0.109800 | 0.959 |
R-HSA-9005891 | Loss of function of MECP2 in Rett syndrome | 0.109800 | 0.959 |
R-HSA-9697154 | Disorders of Nervous System Development | 0.109800 | 0.959 |
R-HSA-3270619 | IRF3-mediated induction of type I IFN | 0.129015 | 0.889 |
R-HSA-8939243 | RUNX1 interacts with co-factors whose precise effect on RUNX1 targets is not kno... | 0.033126 | 1.480 |
R-HSA-5620916 | VxPx cargo-targeting to cilium | 0.166219 | 0.779 |
R-HSA-165054 | Rev-mediated nuclear export of HIV RNA | 0.279216 | 0.554 |
R-HSA-1660514 | Synthesis of PIPs at the Golgi membrane | 0.207636 | 0.683 |
R-HSA-917977 | Transferrin endocytosis and recycling | 0.263289 | 0.580 |
R-HSA-6794362 | Protein-protein interactions at synapses | 0.147083 | 0.832 |
R-HSA-1251985 | Nuclear signaling by ERBB4 | 0.289644 | 0.538 |
R-HSA-9824585 | Regulation of MITF-M-dependent genes involved in pigmentation | 0.057331 | 1.242 |
R-HSA-5689877 | Josephin domain DUBs | 0.090166 | 1.045 |
R-HSA-389359 | CD28 dependent Vav1 pathway | 0.116251 | 0.935 |
R-HSA-9675151 | Disorders of Developmental Biology | 0.141595 | 0.849 |
R-HSA-168276 | NS1 Mediated Effects on Host Pathways | 0.284449 | 0.546 |
R-HSA-68886 | M Phase | 0.170553 | 0.768 |
R-HSA-69275 | G2/M Transition | 0.063124 | 1.200 |
R-HSA-453274 | Mitotic G2-G2/M phases | 0.064924 | 1.188 |
R-HSA-9857377 | Regulation of MITF-M-dependent genes involved in lysosome biogenesis and autopha... | 0.017975 | 1.745 |
R-HSA-1660516 | Synthesis of PIPs at the early endosome membrane | 0.201847 | 0.695 |
R-HSA-1538133 | G0 and Early G1 | 0.241509 | 0.617 |
R-HSA-68875 | Mitotic Prophase | 0.254490 | 0.594 |
R-HSA-8863795 | Downregulation of ERBB2 signaling | 0.230380 | 0.638 |
R-HSA-5620920 | Cargo trafficking to the periciliary membrane | 0.113074 | 0.947 |
R-HSA-3214858 | RMTs methylate histone arginines | 0.055444 | 1.256 |
R-HSA-1474165 | Reproduction | 0.286693 | 0.543 |
R-HSA-69278 | Cell Cycle, Mitotic | 0.064869 | 1.188 |
R-HSA-69620 | Cell Cycle Checkpoints | 0.144913 | 0.839 |
R-HSA-8875360 | InlB-mediated entry of Listeria monocytogenes into host cell | 0.129015 | 0.889 |
R-HSA-8866652 | Synthesis of active ubiquitin: roles of E1 and E2 enzymes | 0.213384 | 0.671 |
R-HSA-211000 | Gene Silencing by RNA | 0.056494 | 1.248 |
R-HSA-8852135 | Protein ubiquitination | 0.122568 | 0.912 |
R-HSA-69481 | G2/M Checkpoints | 0.275963 | 0.559 |
R-HSA-157579 | Telomere Maintenance | 0.185457 | 0.732 |
R-HSA-9842860 | Regulation of endogenous retroelements | 0.198556 | 0.702 |
R-HSA-6787450 | tRNA modification in the mitochondrion | 0.141595 | 0.849 |
R-HSA-389977 | Post-chaperonin tubulin folding pathway | 0.166219 | 0.779 |
R-HSA-2173795 | Downregulation of SMAD2/3:SMAD4 transcriptional activity | 0.241509 | 0.617 |
R-HSA-162909 | Host Interactions of HIV factors | 0.265225 | 0.576 |
R-HSA-6804757 | Regulation of TP53 Degradation | 0.268636 | 0.571 |
R-HSA-9648002 | RAS processing | 0.284449 | 0.546 |
R-HSA-5621575 | CD209 (DC-SIGN) signaling | 0.196015 | 0.708 |
R-HSA-9707564 | Cytoprotection by HMOX1 | 0.142100 | 0.847 |
R-HSA-3214841 | PKMTs methylate histone lysines | 0.294801 | 0.530 |
R-HSA-6806003 | Regulation of TP53 Expression and Degradation | 0.284449 | 0.546 |
R-HSA-6807004 | Negative regulation of MET activity | 0.166219 | 0.779 |
R-HSA-8940973 | RUNX2 regulates osteoblast differentiation | 0.219090 | 0.659 |
R-HSA-3247509 | Chromatin modifying enzymes | 0.114600 | 0.941 |
R-HSA-909733 | Interferon alpha/beta signaling | 0.241088 | 0.618 |
R-HSA-8876384 | Listeria monocytogenes entry into host cells | 0.178267 | 0.749 |
R-HSA-9008059 | Interleukin-37 signaling | 0.028623 | 1.543 |
R-HSA-6804115 | TP53 regulates transcription of additional cell cycle genes whose exact role in ... | 0.184226 | 0.735 |
R-HSA-9022692 | Regulation of MECP2 expression and activity | 0.247013 | 0.607 |
R-HSA-3769402 | Deactivation of the beta-catenin transactivating complex | 0.273945 | 0.562 |
R-HSA-391251 | Protein folding | 0.169919 | 0.770 |
R-HSA-5601884 | PIWI-interacting RNA (piRNA) biogenesis | 0.201847 | 0.695 |
R-HSA-2151201 | Transcriptional activation of mitochondrial biogenesis | 0.027563 | 1.560 |
R-HSA-8941326 | RUNX2 regulates bone development | 0.268636 | 0.571 |
R-HSA-8953750 | Transcriptional Regulation by E2F6 | 0.044609 | 1.351 |
R-HSA-6804116 | TP53 Regulates Transcription of Genes Involved in G1 Cell Cycle Arrest | 0.135328 | 0.869 |
R-HSA-264876 | Insulin processing | 0.213384 | 0.671 |
R-HSA-202433 | Generation of second messenger molecules | 0.289644 | 0.538 |
R-HSA-69273 | Cyclin A/B1/B2 associated events during G2/M transition | 0.033126 | 1.480 |
R-HSA-168638 | NOD1/2 Signaling Pathway | 0.257903 | 0.589 |
R-HSA-1839126 | FGFR2 mutant receptor activation | 0.268636 | 0.571 |
R-HSA-1592230 | Mitochondrial biogenesis | 0.070903 | 1.149 |
R-HSA-9856651 | MITF-M-dependent gene expression | 0.034753 | 1.459 |
R-HSA-1834941 | STING mediated induction of host immune responses | 0.160129 | 0.796 |
R-HSA-72306 | tRNA processing | 0.159179 | 0.798 |
R-HSA-164952 | The role of Nef in HIV-1 replication and disease pathogenesis | 0.190142 | 0.721 |
R-HSA-6791312 | TP53 Regulates Transcription of Cell Cycle Genes | 0.081600 | 1.088 |
R-HSA-9006934 | Signaling by Receptor Tyrosine Kinases | 0.091408 | 1.039 |
R-HSA-9700206 | Signaling by ALK in cancer | 0.214416 | 0.669 |
R-HSA-9730414 | MITF-M-regulated melanocyte development | 0.090709 | 1.042 |
R-HSA-3700989 | Transcriptional Regulation by TP53 | 0.279059 | 0.554 |
R-HSA-9725370 | Signaling by ALK fusions and activated point mutants | 0.214416 | 0.669 |
R-HSA-8950505 | Gene and protein expression by JAK-STAT signaling after Interleukin-12 stimulati... | 0.099224 | 1.003 |
R-HSA-9020591 | Interleukin-12 signaling | 0.124972 | 0.903 |
R-HSA-447115 | Interleukin-12 family signaling | 0.154624 | 0.811 |
R-HSA-167162 | RNA Polymerase II HIV Promoter Escape | 0.299922 | 0.523 |
R-HSA-167161 | HIV Transcription Initiation | 0.299922 | 0.523 |
R-HSA-75953 | RNA Polymerase II Transcription Initiation | 0.299922 | 0.523 |
R-HSA-73776 | RNA Polymerase II Promoter Escape | 0.310053 | 0.509 |
R-HSA-187577 | SCF(Skp2)-mediated degradation of p27/p21 | 0.315063 | 0.502 |
R-HSA-69231 | Cyclin D associated events in G1 | 0.315063 | 0.502 |
R-HSA-69236 | G1 Phase | 0.315063 | 0.502 |
R-HSA-76042 | RNA Polymerase II Transcription Initiation And Promoter Clearance | 0.320038 | 0.495 |
R-HSA-774815 | Nucleosome assembly | 0.320038 | 0.495 |
R-HSA-606279 | Deposition of new CENPA-containing nucleosomes at the centromere | 0.320038 | 0.495 |
R-HSA-168333 | NEP/NS2 Interacts with the Cellular Export Machinery | 0.320038 | 0.495 |
R-HSA-5688426 | Deubiquitination | 0.322791 | 0.491 |
R-HSA-162599 | Late Phase of HIV Life Cycle | 0.324078 | 0.489 |
R-HSA-72165 | mRNA Splicing - Minor Pathway | 0.324977 | 0.488 |
R-HSA-168274 | Export of Viral Ribonucleoproteins from Nucleus | 0.324977 | 0.488 |
R-HSA-75153 | Apoptotic execution phase | 0.324977 | 0.488 |
R-HSA-389356 | Co-stimulation by CD28 | 0.334748 | 0.475 |
R-HSA-9766229 | Degradation of CDH1 | 0.339581 | 0.469 |
R-HSA-2122947 | NOTCH1 Intracellular Domain Regulates Transcription | 0.339581 | 0.469 |
R-HSA-532668 | N-glycan trimming in the ER and Calnexin/Calreticulin cycle | 0.339581 | 0.469 |
R-HSA-69563 | p53-Dependent G1 DNA Damage Response | 0.339581 | 0.469 |
R-HSA-69580 | p53-Dependent G1/S DNA damage checkpoint | 0.339581 | 0.469 |
R-HSA-9758941 | Gastrulation | 0.342601 | 0.465 |
R-HSA-5655253 | Signaling by FGFR2 in disease | 0.344379 | 0.463 |
R-HSA-9755511 | KEAP1-NFE2L2 pathway | 0.347866 | 0.459 |
R-HSA-9711123 | Cellular response to chemical stress | 0.348571 | 0.458 |
R-HSA-5663202 | Diseases of signal transduction by growth factor receptors and second messengers | 0.350177 | 0.456 |
R-HSA-446652 | Interleukin-1 family signaling | 0.350493 | 0.455 |
R-HSA-69306 | DNA Replication | 0.353117 | 0.452 |
R-HSA-112382 | Formation of RNA Pol II elongation complex | 0.353872 | 0.451 |
R-HSA-8866654 | E3 ubiquitin ligases ubiquitinate target proteins | 0.353872 | 0.451 |
R-HSA-168273 | Influenza Viral RNA Transcription and Replication | 0.358354 | 0.446 |
R-HSA-75955 | RNA Polymerase II Transcription Elongation | 0.358567 | 0.445 |
R-HSA-9639288 | Amino acids regulate mTORC1 | 0.358567 | 0.445 |
R-HSA-445355 | Smooth Muscle Contraction | 0.358567 | 0.445 |
R-HSA-69017 | CDK-mediated phosphorylation and removal of Cdc6 | 0.363229 | 0.440 |
R-HSA-162587 | HIV Life Cycle | 0.363575 | 0.439 |
R-HSA-3214815 | HDACs deacetylate histones | 0.367856 | 0.434 |
R-HSA-877300 | Interferon gamma signaling | 0.368781 | 0.433 |
R-HSA-5633007 | Regulation of TP53 Activity | 0.371378 | 0.430 |
R-HSA-9662361 | Sensory processing of sound by outer hair cells of the cochlea | 0.372451 | 0.429 |
R-HSA-2173793 | Transcriptional activity of SMAD2/SMAD3:SMAD4 heterotrimer | 0.372451 | 0.429 |
R-HSA-2980766 | Nuclear Envelope Breakdown | 0.377012 | 0.424 |
R-HSA-9764561 | Regulation of CDH1 Function | 0.377012 | 0.424 |
R-HSA-9029569 | NR1H3 & NR1H2 regulate gene expression linked to cholesterol transport and efflu... | 0.381540 | 0.418 |
R-HSA-194441 | Metabolism of non-coding RNA | 0.386036 | 0.413 |
R-HSA-191859 | snRNP Assembly | 0.386036 | 0.413 |
R-HSA-5693565 | Recruitment and ATM-mediated phosphorylation of repair and signaling proteins at... | 0.386036 | 0.413 |
R-HSA-429914 | Deadenylation-dependent mRNA decay | 0.386036 | 0.413 |
R-HSA-2644602 | Signaling by NOTCH1 PEST Domain Mutants in Cancer | 0.390500 | 0.408 |
R-HSA-2894858 | Signaling by NOTCH1 HD+PEST Domain Mutants in Cancer | 0.390500 | 0.408 |
R-HSA-2644606 | Constitutive Signaling by NOTCH1 PEST Domain Mutants | 0.390500 | 0.408 |
R-HSA-2894862 | Constitutive Signaling by NOTCH1 HD+PEST Domain Mutants | 0.390500 | 0.408 |
R-HSA-1227986 | Signaling by ERBB2 | 0.390500 | 0.408 |
R-HSA-2644603 | Signaling by NOTCH1 in Cancer | 0.390500 | 0.408 |
R-HSA-6784531 | tRNA processing in the nucleus | 0.399330 | 0.399 |
R-HSA-2559586 | DNA Damage/Telomere Stress Induced Senescence | 0.399330 | 0.399 |
R-HSA-5621481 | C-type lectin receptors (CLRs) | 0.402195 | 0.396 |
R-HSA-373755 | Semaphorin interactions | 0.403698 | 0.394 |
R-HSA-69615 | G1/S DNA Damage Checkpoints | 0.403698 | 0.394 |
R-HSA-168643 | Nucleotide-binding domain, leucine rich repeat containing receptor (NLR) signali... | 0.408034 | 0.389 |
R-HSA-6802952 | Signaling by BRAF and RAF1 fusions | 0.412338 | 0.385 |
R-HSA-9909649 | Regulation of PD-L1(CD274) transcription | 0.416612 | 0.380 |
R-HSA-6782315 | tRNA modification in the nucleus and cytosol | 0.416612 | 0.380 |
R-HSA-5693606 | DNA Double Strand Break Response | 0.420855 | 0.376 |
R-HSA-168255 | Influenza Infection | 0.422349 | 0.374 |
R-HSA-167172 | Transcription of the HIV genome | 0.425067 | 0.372 |
R-HSA-5218859 | Regulated Necrosis | 0.425067 | 0.372 |
R-HSA-9662360 | Sensory processing of sound by inner hair cells of the cochlea | 0.425067 | 0.372 |
R-HSA-913709 | O-linked glycosylation of mucins | 0.425067 | 0.372 |
R-HSA-69202 | Cyclin E associated events during G1/S transition | 0.433401 | 0.363 |
R-HSA-1834949 | Cytosolic sensors of pathogen-associated DNA | 0.433401 | 0.363 |
R-HSA-69656 | Cyclin A:Cdk2-associated events at S phase entry | 0.441615 | 0.355 |
R-HSA-159236 | Transport of Mature mRNA derived from an Intron-Containing Transcript | 0.445678 | 0.351 |
R-HSA-69052 | Switching of origins to a post-replicative state | 0.445678 | 0.351 |
R-HSA-1445148 | Translocation of SLC2A4 (GLUT4) to the plasma membrane | 0.445678 | 0.351 |
R-HSA-983712 | Ion channel transport | 0.447048 | 0.350 |
R-HSA-674695 | RNA Polymerase II Pre-transcription Events | 0.449711 | 0.347 |
R-HSA-425397 | Transport of vitamins, nucleosides, and related molecules | 0.449711 | 0.347 |
R-HSA-1236394 | Signaling by ERBB4 | 0.449711 | 0.347 |
R-HSA-1222556 | ROS and RNS production in phagocytes | 0.449711 | 0.347 |
R-HSA-1226099 | Signaling by FGFR in disease | 0.449711 | 0.347 |
R-HSA-1169408 | ISG15 antiviral mechanism | 0.453715 | 0.343 |
R-HSA-917937 | Iron uptake and transport | 0.453715 | 0.343 |
R-HSA-212165 | Epigenetic regulation of gene expression | 0.455530 | 0.341 |
R-HSA-5689603 | UCH proteinases | 0.457691 | 0.339 |
R-HSA-1980143 | Signaling by NOTCH1 | 0.457691 | 0.339 |
R-HSA-9024446 | NR1H2 and NR1H3-mediated signaling | 0.461637 | 0.336 |
R-HSA-9609690 | HCMV Early Events | 0.463987 | 0.333 |
R-HSA-383280 | Nuclear Receptor transcription pathway | 0.465555 | 0.332 |
R-HSA-6796648 | TP53 Regulates Transcription of DNA Repair Genes | 0.465555 | 0.332 |
R-HSA-9659379 | Sensory processing of sound | 0.469445 | 0.328 |
R-HSA-5654738 | Signaling by FGFR2 | 0.473307 | 0.325 |
R-HSA-6806834 | Signaling by MET | 0.473307 | 0.325 |
R-HSA-376176 | Signaling by ROBO receptors | 0.480623 | 0.318 |
R-HSA-72202 | Transport of Mature Transcript to Cytoplasm | 0.480947 | 0.318 |
R-HSA-74160 | Gene expression (Transcription) | 0.481212 | 0.318 |
R-HSA-5357801 | Programmed Cell Death | 0.487657 | 0.312 |
R-HSA-6802957 | Oncogenic MAPK signaling | 0.492202 | 0.308 |
R-HSA-5687128 | MAPK6/MAPK4 signaling | 0.492202 | 0.308 |
R-HSA-141424 | Amplification of signal from the kinetochores | 0.495899 | 0.305 |
R-HSA-141444 | Amplification of signal from unattached kinetochores via a MAD2 inhibitory si... | 0.495899 | 0.305 |
R-HSA-6807505 | RNA polymerase II transcribes snRNA genes | 0.499570 | 0.301 |
R-HSA-6804756 | Regulation of TP53 Activity through Phosphorylation | 0.499570 | 0.301 |
R-HSA-390466 | Chaperonin-mediated protein folding | 0.503215 | 0.298 |
R-HSA-9645723 | Diseases of programmed cell death | 0.506833 | 0.295 |
R-HSA-8986944 | Transcriptional Regulation by MECP2 | 0.517531 | 0.286 |
R-HSA-74752 | Signaling by Insulin receptor | 0.524535 | 0.280 |
R-HSA-2682334 | EPH-Ephrin signaling | 0.524535 | 0.280 |
R-HSA-8878171 | Transcriptional regulation by RUNX1 | 0.535208 | 0.271 |
R-HSA-72764 | Eukaryotic Translation Termination | 0.538241 | 0.269 |
R-HSA-5389840 | Mitochondrial translation elongation | 0.541606 | 0.266 |
R-HSA-6807878 | COPI-mediated anterograde transport | 0.541606 | 0.266 |
R-HSA-5607764 | CLEC7A (Dectin-1) signaling | 0.541606 | 0.266 |
R-HSA-381340 | Transcriptional regulation of white adipocyte differentiation | 0.541606 | 0.266 |
R-HSA-170834 | Signaling by TGF-beta Receptor Complex | 0.544947 | 0.264 |
R-HSA-5368286 | Mitochondrial translation initiation | 0.548264 | 0.261 |
R-HSA-190236 | Signaling by FGFR | 0.548264 | 0.261 |
R-HSA-3214847 | HATs acetylate histones | 0.551556 | 0.258 |
R-HSA-193704 | p75 NTR receptor-mediated signalling | 0.551556 | 0.258 |
R-HSA-69618 | Mitotic Spindle Checkpoint | 0.554825 | 0.256 |
R-HSA-70171 | Glycolysis | 0.554825 | 0.256 |
R-HSA-1483255 | PI Metabolism | 0.561292 | 0.251 |
R-HSA-3371453 | Regulation of HSF1-mediated heat shock response | 0.561292 | 0.251 |
R-HSA-9937383 | Mitochondrial ribosome-associated quality control | 0.564491 | 0.248 |
R-HSA-913531 | Interferon Signaling | 0.564892 | 0.248 |
R-HSA-8856825 | Cargo recognition for clathrin-mediated endocytosis | 0.567666 | 0.246 |
R-HSA-1799339 | SRP-dependent cotranslational protein targeting to membrane | 0.580139 | 0.236 |
R-HSA-69239 | Synthesis of DNA | 0.580139 | 0.236 |
R-HSA-2672351 | Stimuli-sensing channels | 0.583201 | 0.234 |
R-HSA-9609646 | HCMV Infection | 0.585784 | 0.232 |
R-HSA-5419276 | Mitochondrial translation termination | 0.586241 | 0.232 |
R-HSA-9648025 | EML4 and NUDC in mitotic spindle formation | 0.586241 | 0.232 |
R-HSA-202403 | TCR signaling | 0.589259 | 0.230 |
R-HSA-2871796 | FCERI mediated MAPK activation | 0.595230 | 0.225 |
R-HSA-1483249 | Inositol phosphate metabolism | 0.595230 | 0.225 |
R-HSA-388841 | Regulation of T cell activation by CD28 family | 0.597784 | 0.223 |
R-HSA-168181 | Toll Like Receptor 7/8 (TLR7/8) Cascade | 0.598183 | 0.223 |
R-HSA-212436 | Generic Transcription Pathway | 0.598665 | 0.223 |
R-HSA-168138 | Toll Like Receptor 9 (TLR9) Cascade | 0.606915 | 0.217 |
R-HSA-4420097 | VEGFA-VEGFR2 Pathway | 0.609783 | 0.215 |
R-HSA-373760 | L1CAM interactions | 0.612631 | 0.213 |
R-HSA-70326 | Glucose metabolism | 0.615458 | 0.211 |
R-HSA-2980736 | Peptide hormone metabolism | 0.615458 | 0.211 |
R-HSA-8878166 | Transcriptional regulation by RUNX2 | 0.621051 | 0.207 |
R-HSA-2500257 | Resolution of Sister Chromatid Cohesion | 0.626564 | 0.203 |
R-HSA-3371556 | Cellular response to heat stress | 0.626564 | 0.203 |
R-HSA-9816359 | Maternal to zygotic transition (MZT) | 0.631997 | 0.199 |
R-HSA-72766 | Translation | 0.638085 | 0.195 |
R-HSA-69206 | G1/S Transition | 0.639999 | 0.194 |
R-HSA-9841922 | MLL4 and MLL3 complexes regulate expression of PPARG target genes in adipogenesi... | 0.639999 | 0.194 |
R-HSA-9851695 | Epigenetic regulation of adipogenesis genes by MLL3 and MLL4 complexes | 0.639999 | 0.194 |
R-HSA-194138 | Signaling by VEGF | 0.639999 | 0.194 |
R-HSA-9818564 | Epigenetic regulation of gene expression by MLL3 and MLL4 complexes | 0.639999 | 0.194 |
R-HSA-72203 | Processing of Capped Intron-Containing Pre-mRNA | 0.641382 | 0.193 |
R-HSA-114608 | Platelet degranulation | 0.645238 | 0.190 |
R-HSA-9843745 | Adipogenesis | 0.658008 | 0.182 |
R-HSA-9909396 | Circadian clock | 0.660506 | 0.180 |
R-HSA-76005 | Response to elevated platelet cytosolic Ca2+ | 0.662987 | 0.178 |
R-HSA-1483257 | Phospholipid metabolism | 0.669485 | 0.174 |
R-HSA-9018519 | Estrogen-dependent gene expression | 0.672730 | 0.172 |
R-HSA-5173105 | O-linked glycosylation | 0.675122 | 0.171 |
R-HSA-5368287 | Mitochondrial translation | 0.677497 | 0.169 |
R-HSA-6798695 | Neutrophil degranulation | 0.678285 | 0.169 |
R-HSA-6807070 | PTEN Regulation | 0.679854 | 0.168 |
R-HSA-9705671 | SARS-CoV-2 activates/modulates innate and adaptive immune responses | 0.689114 | 0.162 |
R-HSA-1280215 | Cytokine Signaling in Immune system | 0.689749 | 0.161 |
R-HSA-8856828 | Clathrin-mediated endocytosis | 0.691388 | 0.160 |
R-HSA-449147 | Signaling by Interleukins | 0.694788 | 0.158 |
R-HSA-453279 | Mitotic G1 phase and G1/S transition | 0.698109 | 0.156 |
R-HSA-199977 | ER to Golgi Anterograde Transport | 0.700317 | 0.155 |
R-HSA-69242 | S Phase | 0.702509 | 0.153 |
R-HSA-9679191 | Potential therapeutics for SARS | 0.706845 | 0.151 |
R-HSA-73857 | RNA Polymerase II Transcription | 0.712593 | 0.147 |
R-HSA-9917777 | Epigenetic regulation by WDR5-containing histone modifying complexes | 0.715331 | 0.145 |
R-HSA-73887 | Death Receptor Signaling | 0.715331 | 0.145 |
R-HSA-1169410 | Antiviral mechanism by IFN-stimulated genes | 0.715331 | 0.145 |
R-HSA-1989781 | PPARA activates gene expression | 0.717414 | 0.144 |
R-HSA-400206 | Regulation of lipid metabolism by PPARalpha | 0.721535 | 0.142 |
R-HSA-9610379 | HCMV Late Events | 0.721535 | 0.142 |
R-HSA-9711097 | Cellular response to starvation | 0.723573 | 0.141 |
R-HSA-9006936 | Signaling by TGFB family members | 0.727605 | 0.138 |
R-HSA-109581 | Apoptosis | 0.731578 | 0.136 |
R-HSA-2467813 | Separation of Sister Chromatids | 0.735494 | 0.133 |
R-HSA-5619102 | SLC transporter disorders | 0.741262 | 0.130 |
R-HSA-5683057 | MAPK family signaling cascades | 0.748752 | 0.126 |
R-HSA-8953854 | Metabolism of RNA | 0.750756 | 0.125 |
R-HSA-9909648 | Regulation of PD-L1(CD274) expression | 0.752427 | 0.124 |
R-HSA-5689880 | Ub-specific processing proteases | 0.754241 | 0.122 |
R-HSA-9764265 | Regulation of CDH1 Expression and Function | 0.754241 | 0.122 |
R-HSA-9764274 | Regulation of Expression and Function of Type I Classical Cadherins | 0.754241 | 0.122 |
R-HSA-2559583 | Cellular Senescence | 0.766573 | 0.115 |
R-HSA-9006931 | Signaling by Nuclear Receptors | 0.769655 | 0.114 |
R-HSA-201681 | TCF dependent signaling in response to WNT | 0.771669 | 0.113 |
R-HSA-2262752 | Cellular responses to stress | 0.773011 | 0.112 |
R-HSA-168249 | Innate Immune System | 0.773748 | 0.111 |
R-HSA-1266738 | Developmental Biology | 0.781329 | 0.107 |
R-HSA-422475 | Axon guidance | 0.783119 | 0.106 |
R-HSA-168898 | Toll-like Receptor Cascades | 0.784725 | 0.105 |
R-HSA-72163 | mRNA Splicing - Major Pathway | 0.789428 | 0.103 |
R-HSA-392499 | Metabolism of proteins | 0.789594 | 0.103 |
R-HSA-9759476 | Regulation of Homotypic Cell-Cell Adhesion | 0.792506 | 0.101 |
R-HSA-389948 | Co-inhibition by PD-1 | 0.798530 | 0.098 |
R-HSA-948021 | Transport to the Golgi and subsequent modification | 0.801476 | 0.096 |
R-HSA-2454202 | Fc epsilon receptor (FCERI) signaling | 0.802933 | 0.095 |
R-HSA-1483206 | Glycerophospholipid biosynthesis | 0.802933 | 0.095 |
R-HSA-72172 | mRNA Splicing | 0.805816 | 0.094 |
R-HSA-397014 | Muscle contraction | 0.816934 | 0.088 |
R-HSA-9675108 | Nervous system development | 0.818040 | 0.087 |
R-HSA-68882 | Mitotic Anaphase | 0.822254 | 0.085 |
R-HSA-2555396 | Mitotic Metaphase and Anaphase | 0.823560 | 0.084 |
R-HSA-418990 | Adherens junctions interactions | 0.824856 | 0.084 |
R-HSA-8951664 | Neddylation | 0.828689 | 0.082 |
R-HSA-446203 | Asparagine N-linked glycosylation | 0.835186 | 0.078 |
R-HSA-9705683 | SARS-CoV-2-host interactions | 0.837312 | 0.077 |
R-HSA-8939211 | ESR-mediated signaling | 0.847769 | 0.072 |
R-HSA-157118 | Signaling by NOTCH | 0.851104 | 0.070 |
R-HSA-8953897 | Cellular responses to stimuli | 0.858073 | 0.066 |
R-HSA-5619115 | Disorders of transmembrane transporters | 0.858607 | 0.066 |
R-HSA-421270 | Cell-cell junction organization | 0.862725 | 0.064 |
R-HSA-162582 | Signal Transduction | 0.865329 | 0.063 |
R-HSA-199991 | Membrane Trafficking | 0.868616 | 0.061 |
R-HSA-597592 | Post-translational protein modification | 0.871923 | 0.060 |
R-HSA-112316 | Neuronal System | 0.873572 | 0.059 |
R-HSA-76002 | Platelet activation, signaling and aggregation | 0.884197 | 0.053 |
R-HSA-446728 | Cell junction organization | 0.887575 | 0.052 |
R-HSA-983168 | Antigen processing: Ubiquitination & Proteasome degradation | 0.890856 | 0.050 |
R-HSA-5673001 | RAF/MAP kinase cascade | 0.896370 | 0.048 |
R-HSA-1257604 | PIP3 activates AKT signaling | 0.900876 | 0.045 |
R-HSA-5684996 | MAPK1/MAPK3 signaling | 0.901608 | 0.045 |
R-HSA-195721 | Signaling by WNT | 0.903056 | 0.044 |
R-HSA-1500931 | Cell-Cell communication | 0.915171 | 0.038 |
R-HSA-9679506 | SARS-CoV Infections | 0.924714 | 0.034 |
R-HSA-9824446 | Viral Infection Pathways | 0.925805 | 0.033 |
R-HSA-168256 | Immune System | 0.926039 | 0.033 |
R-HSA-9006925 | Intracellular signaling by second messengers | 0.930066 | 0.031 |
R-HSA-9694516 | SARS-CoV-2 Infection | 0.933613 | 0.030 |
R-HSA-5653656 | Vesicle-mediated transport | 0.943612 | 0.025 |
R-HSA-983169 | Class I MHC mediated antigen processing & presentation | 0.948840 | 0.023 |
R-HSA-9824439 | Bacterial Infection Pathways | 0.951441 | 0.022 |
R-HSA-425407 | SLC-mediated transmembrane transport | 0.953911 | 0.020 |
R-HSA-71387 | Metabolism of carbohydrates and carbohydrate derivatives | 0.970122 | 0.013 |
R-HSA-382551 | Transport of small molecules | 0.978981 | 0.009 |
R-HSA-1643685 | Disease | 0.981807 | 0.008 |
R-HSA-1280218 | Adaptive Immune System | 0.985723 | 0.006 |
R-HSA-5663205 | Infectious disease | 0.988290 | 0.005 |
R-HSA-109582 | Hemostasis | 0.997522 | 0.001 |
R-HSA-556833 | Metabolism of lipids | 0.999143 | 0.000 |
R-HSA-9709957 | Sensory Perception | 0.999926 | 0.000 |
R-HSA-1430728 | Metabolism | 1.000000 | 0.000 |
Download
kinase | JSD_mean | pearson_surrounding | kinase_max_IC_position | max_position_JSD |
---|---|---|---|---|
JNK2 |
0.851 | 0.825 | 1 | 0.888 |
P38G |
0.850 | 0.816 | 1 | 0.911 |
HIPK2 |
0.850 | 0.735 | 1 | 0.871 |
CDK17 |
0.846 | 0.792 | 1 | 0.903 |
DYRK4 |
0.846 | 0.747 | 1 | 0.878 |
DYRK2 |
0.846 | 0.726 | 1 | 0.800 |
CDK18 |
0.846 | 0.775 | 1 | 0.886 |
CDK8 |
0.844 | 0.759 | 1 | 0.848 |
ERK1 |
0.843 | 0.777 | 1 | 0.871 |
CDK7 |
0.843 | 0.757 | 1 | 0.851 |
CDK19 |
0.843 | 0.749 | 1 | 0.880 |
P38D |
0.842 | 0.787 | 1 | 0.919 |
DYRK1B |
0.841 | 0.731 | 1 | 0.842 |
P38B |
0.841 | 0.772 | 1 | 0.850 |
JNK3 |
0.839 | 0.805 | 1 | 0.858 |
CDK1 |
0.839 | 0.756 | 1 | 0.861 |
KIS |
0.838 | 0.690 | 1 | 0.828 |
CDK3 |
0.838 | 0.696 | 1 | 0.898 |
CDK12 |
0.837 | 0.766 | 1 | 0.884 |
CLK3 |
0.837 | 0.524 | 1 | 0.569 |
HIPK1 |
0.837 | 0.682 | 1 | 0.788 |
CDK13 |
0.836 | 0.755 | 1 | 0.868 |
CDK16 |
0.836 | 0.755 | 1 | 0.895 |
P38A |
0.835 | 0.758 | 1 | 0.800 |
CDK14 |
0.834 | 0.766 | 1 | 0.861 |
ERK2 |
0.834 | 0.783 | 1 | 0.828 |
NLK |
0.831 | 0.707 | 1 | 0.622 |
CDK10 |
0.830 | 0.721 | 1 | 0.873 |
DYRK3 |
0.829 | 0.594 | 1 | 0.753 |
CLK4 |
0.828 | 0.464 | -3 | 0.702 |
HIPK3 |
0.826 | 0.662 | 1 | 0.768 |
CDK5 |
0.826 | 0.709 | 1 | 0.827 |
CDK9 |
0.826 | 0.737 | 1 | 0.865 |
CLK1 |
0.826 | 0.468 | -3 | 0.678 |
DYRK1A |
0.824 | 0.585 | 1 | 0.768 |
JNK1 |
0.823 | 0.726 | 1 | 0.878 |
HIPK4 |
0.822 | 0.439 | 1 | 0.607 |
CLK2 |
0.821 | 0.452 | -3 | 0.676 |
CDK4 |
0.820 | 0.741 | 1 | 0.892 |
CDK6 |
0.817 | 0.712 | 1 | 0.878 |
SRPK1 |
0.816 | 0.312 | -3 | 0.669 |
ERK5 |
0.816 | 0.380 | 1 | 0.524 |
CDK2 |
0.812 | 0.585 | 1 | 0.758 |
ICK |
0.809 | 0.358 | -3 | 0.752 |
MAK |
0.807 | 0.477 | -2 | 0.804 |
SRPK2 |
0.804 | 0.248 | -3 | 0.604 |
COT |
0.804 | -0.025 | 2 | 0.892 |
MTOR |
0.804 | 0.189 | 1 | 0.414 |
PRP4 |
0.802 | 0.446 | -3 | 0.719 |
CDKL1 |
0.799 | 0.130 | -3 | 0.723 |
CDKL5 |
0.797 | 0.143 | -3 | 0.711 |
MOK |
0.795 | 0.439 | 1 | 0.679 |
AURC |
0.795 | 0.171 | -2 | 0.828 |
SRPK3 |
0.794 | 0.203 | -3 | 0.648 |
RSK2 |
0.794 | 0.063 | -3 | 0.695 |
CAMLCK |
0.794 | 0.110 | -2 | 0.909 |
CDC7 |
0.793 | -0.083 | 1 | 0.235 |
CAMK1B |
0.793 | 0.028 | -3 | 0.784 |
PIM3 |
0.793 | -0.002 | -3 | 0.755 |
MOS |
0.792 | -0.028 | 1 | 0.286 |
SKMLCK |
0.792 | 0.054 | -2 | 0.909 |
PRPK |
0.792 | -0.092 | -1 | 0.801 |
TBK1 |
0.792 | -0.124 | 1 | 0.226 |
IKKB |
0.791 | -0.111 | -2 | 0.705 |
IKKE |
0.790 | -0.127 | 1 | 0.221 |
RAF1 |
0.790 | -0.135 | 1 | 0.249 |
PIM1 |
0.789 | 0.056 | -3 | 0.709 |
P70S6KB |
0.789 | 0.060 | -3 | 0.717 |
RIPK3 |
0.789 | -0.060 | 3 | 0.762 |
AURB |
0.789 | 0.151 | -2 | 0.824 |
PAK6 |
0.789 | 0.137 | -2 | 0.861 |
DAPK2 |
0.789 | 0.058 | -3 | 0.784 |
PKACG |
0.788 | 0.081 | -2 | 0.846 |
WNK1 |
0.788 | -0.021 | -2 | 0.873 |
ATR |
0.788 | -0.045 | 1 | 0.295 |
BMPR2 |
0.788 | -0.139 | -2 | 0.822 |
CAMK2G |
0.787 | -0.044 | 2 | 0.825 |
PAK1 |
0.787 | 0.094 | -2 | 0.895 |
NDR1 |
0.787 | 0.006 | -3 | 0.749 |
P90RSK |
0.787 | 0.030 | -3 | 0.700 |
RSK3 |
0.786 | 0.038 | -3 | 0.692 |
MST4 |
0.786 | -0.019 | 2 | 0.831 |
PDHK4 |
0.785 | -0.155 | 1 | 0.310 |
DSTYK |
0.785 | -0.118 | 2 | 0.900 |
GCN2 |
0.785 | -0.157 | 2 | 0.803 |
PAK3 |
0.785 | 0.070 | -2 | 0.890 |
NIK |
0.785 | -0.021 | -3 | 0.797 |
PRKD2 |
0.785 | 0.020 | -3 | 0.685 |
PKN3 |
0.785 | -0.036 | -3 | 0.749 |
GRK1 |
0.784 | 0.004 | -2 | 0.713 |
PKACB |
0.784 | 0.132 | -2 | 0.831 |
NDR2 |
0.784 | -0.021 | -3 | 0.753 |
ERK7 |
0.783 | 0.246 | 2 | 0.548 |
RSK4 |
0.783 | 0.074 | -3 | 0.674 |
PKCD |
0.783 | 0.009 | 2 | 0.788 |
GRK6 |
0.782 | -0.040 | 1 | 0.232 |
PKG2 |
0.781 | 0.107 | -2 | 0.822 |
ULK2 |
0.781 | -0.191 | 2 | 0.791 |
TGFBR2 |
0.781 | -0.081 | -2 | 0.758 |
MNK2 |
0.781 | 0.078 | -2 | 0.893 |
AURA |
0.781 | 0.132 | -2 | 0.798 |
WNK3 |
0.780 | -0.132 | 1 | 0.255 |
MLK1 |
0.780 | -0.118 | 2 | 0.814 |
PAK2 |
0.780 | 0.073 | -2 | 0.883 |
PKN2 |
0.780 | -0.036 | -3 | 0.749 |
NEK7 |
0.780 | -0.156 | -3 | 0.761 |
NUAK2 |
0.780 | -0.011 | -3 | 0.768 |
CHAK2 |
0.780 | -0.061 | -1 | 0.832 |
GRK5 |
0.780 | -0.103 | -3 | 0.798 |
PRKD1 |
0.780 | -0.038 | -3 | 0.720 |
PRKX |
0.780 | 0.134 | -3 | 0.625 |
IKKA |
0.780 | -0.062 | -2 | 0.678 |
MSK1 |
0.779 | 0.082 | -3 | 0.662 |
MSK2 |
0.779 | 0.043 | -3 | 0.660 |
MYLK4 |
0.779 | 0.082 | -2 | 0.884 |
BMPR1B |
0.779 | -0.007 | 1 | 0.200 |
PDHK1 |
0.778 | -0.199 | 1 | 0.293 |
RIPK1 |
0.778 | -0.122 | 1 | 0.241 |
GRK7 |
0.778 | 0.034 | 1 | 0.251 |
NEK6 |
0.778 | -0.096 | -2 | 0.795 |
ALK4 |
0.778 | -0.019 | -2 | 0.774 |
ATM |
0.777 | -0.049 | 1 | 0.254 |
AKT2 |
0.777 | 0.080 | -3 | 0.624 |
SGK3 |
0.777 | 0.062 | -3 | 0.679 |
PKR |
0.777 | -0.030 | 1 | 0.271 |
MAPKAPK3 |
0.776 | -0.058 | -3 | 0.681 |
TGFBR1 |
0.776 | -0.019 | -2 | 0.742 |
ANKRD3 |
0.776 | -0.128 | 1 | 0.270 |
PRKD3 |
0.776 | 0.011 | -3 | 0.661 |
DNAPK |
0.776 | -0.024 | 1 | 0.280 |
GSK3A |
0.776 | 0.228 | 4 | 0.555 |
MNK1 |
0.775 | 0.071 | -2 | 0.891 |
CAMK4 |
0.775 | -0.038 | -3 | 0.745 |
PIM2 |
0.774 | 0.056 | -3 | 0.675 |
LATS1 |
0.774 | 0.004 | -3 | 0.762 |
DLK |
0.773 | -0.166 | 1 | 0.252 |
ULK1 |
0.773 | -0.162 | -3 | 0.747 |
PAK5 |
0.773 | 0.112 | -2 | 0.814 |
PLK1 |
0.773 | -0.091 | -2 | 0.749 |
MLK3 |
0.772 | -0.062 | 2 | 0.744 |
NEK9 |
0.772 | -0.190 | 2 | 0.832 |
CAMK2D |
0.772 | -0.107 | -3 | 0.746 |
AMPKA1 |
0.771 | -0.078 | -3 | 0.766 |
FAM20C |
0.771 | 0.048 | 2 | 0.697 |
TTBK2 |
0.771 | -0.143 | 2 | 0.713 |
ALK2 |
0.771 | -0.028 | -2 | 0.746 |
ACVR2A |
0.771 | -0.048 | -2 | 0.736 |
VRK2 |
0.770 | -0.002 | 1 | 0.353 |
MEK1 |
0.770 | -0.088 | 2 | 0.865 |
PKACA |
0.770 | 0.111 | -2 | 0.800 |
LATS2 |
0.770 | -0.062 | -5 | 0.738 |
MAPKAPK2 |
0.770 | -0.041 | -3 | 0.649 |
PAK4 |
0.770 | 0.122 | -2 | 0.820 |
AKT1 |
0.770 | 0.080 | -3 | 0.635 |
TSSK2 |
0.770 | -0.074 | -5 | 0.810 |
ACVR2B |
0.770 | -0.053 | -2 | 0.746 |
MLK2 |
0.770 | -0.159 | 2 | 0.832 |
IRE1 |
0.770 | -0.104 | 1 | 0.246 |
BMPR1A |
0.769 | -0.001 | 1 | 0.188 |
BCKDK |
0.769 | -0.167 | -1 | 0.731 |
PLK3 |
0.769 | -0.045 | 2 | 0.787 |
PINK1 |
0.769 | 0.138 | 1 | 0.451 |
MARK4 |
0.769 | -0.107 | 4 | 0.834 |
HUNK |
0.769 | -0.155 | 2 | 0.799 |
CAMK2B |
0.768 | -0.043 | 2 | 0.819 |
TSSK1 |
0.768 | -0.055 | -3 | 0.778 |
MASTL |
0.768 | -0.223 | -2 | 0.767 |
SMMLCK |
0.768 | 0.064 | -3 | 0.733 |
GRK4 |
0.768 | -0.124 | -2 | 0.730 |
PKCG |
0.767 | -0.019 | 2 | 0.735 |
PKCA |
0.767 | -0.016 | 2 | 0.722 |
NEK2 |
0.766 | -0.113 | 2 | 0.810 |
SMG1 |
0.766 | -0.074 | 1 | 0.280 |
CAMK2A |
0.766 | -0.024 | 2 | 0.821 |
MELK |
0.766 | -0.075 | -3 | 0.715 |
PKCZ |
0.765 | -0.032 | 2 | 0.784 |
AMPKA2 |
0.765 | -0.067 | -3 | 0.735 |
MLK4 |
0.765 | -0.083 | 2 | 0.735 |
PHKG1 |
0.765 | -0.079 | -3 | 0.740 |
NIM1 |
0.765 | -0.107 | 3 | 0.756 |
PKCB |
0.764 | -0.038 | 2 | 0.741 |
DRAK1 |
0.764 | -0.101 | 1 | 0.193 |
DAPK3 |
0.764 | 0.081 | -3 | 0.723 |
PKCH |
0.764 | -0.034 | 2 | 0.719 |
MPSK1 |
0.763 | 0.008 | 1 | 0.322 |
SGK1 |
0.763 | 0.089 | -3 | 0.547 |
WNK4 |
0.763 | -0.077 | -2 | 0.855 |
P70S6K |
0.762 | 0.007 | -3 | 0.631 |
YSK4 |
0.762 | -0.184 | 1 | 0.226 |
IRE2 |
0.762 | -0.108 | 2 | 0.734 |
TLK2 |
0.761 | -0.124 | 1 | 0.236 |
GSK3B |
0.761 | 0.086 | 4 | 0.547 |
MAPKAPK5 |
0.761 | -0.078 | -3 | 0.627 |
QIK |
0.761 | -0.111 | -3 | 0.755 |
PERK |
0.760 | -0.132 | -2 | 0.782 |
MEKK3 |
0.760 | -0.126 | 1 | 0.252 |
CHAK1 |
0.760 | -0.150 | 2 | 0.779 |
DAPK1 |
0.759 | 0.075 | -3 | 0.710 |
AKT3 |
0.759 | 0.076 | -3 | 0.560 |
GRK2 |
0.759 | -0.069 | -2 | 0.634 |
CHK1 |
0.759 | -0.081 | -3 | 0.752 |
NUAK1 |
0.759 | -0.073 | -3 | 0.713 |
GAK |
0.758 | 0.003 | 1 | 0.316 |
MRCKB |
0.758 | 0.087 | -3 | 0.663 |
MEK5 |
0.758 | -0.143 | 2 | 0.837 |
MEKK1 |
0.758 | -0.149 | 1 | 0.266 |
HRI |
0.758 | -0.166 | -2 | 0.803 |
PKCI |
0.758 | 0.016 | 2 | 0.745 |
IRAK4 |
0.758 | -0.104 | 1 | 0.238 |
CAMK1G |
0.758 | -0.038 | -3 | 0.683 |
DCAMKL1 |
0.757 | -0.050 | -3 | 0.708 |
QSK |
0.757 | -0.075 | 4 | 0.806 |
BRAF |
0.757 | -0.117 | -4 | 0.768 |
MST3 |
0.757 | -0.065 | 2 | 0.822 |
MEKK2 |
0.757 | -0.109 | 2 | 0.816 |
MRCKA |
0.757 | 0.077 | -3 | 0.679 |
PKCT |
0.756 | -0.020 | 2 | 0.730 |
TAO3 |
0.756 | -0.061 | 1 | 0.272 |
PLK4 |
0.755 | -0.133 | 2 | 0.624 |
DCAMKL2 |
0.755 | -0.047 | -3 | 0.733 |
ZAK |
0.755 | -0.160 | 1 | 0.233 |
DMPK1 |
0.755 | 0.127 | -3 | 0.689 |
HASPIN |
0.754 | 0.111 | -1 | 0.815 |
ROCK2 |
0.754 | 0.071 | -3 | 0.707 |
SIK |
0.754 | -0.078 | -3 | 0.690 |
PASK |
0.753 | -0.052 | -3 | 0.775 |
NEK5 |
0.753 | -0.165 | 1 | 0.255 |
PHKG2 |
0.753 | -0.064 | -3 | 0.722 |
BRSK1 |
0.753 | -0.084 | -3 | 0.706 |
TLK1 |
0.753 | -0.142 | -2 | 0.749 |
SBK |
0.752 | 0.101 | -3 | 0.512 |
PDK1 |
0.752 | -0.067 | 1 | 0.276 |
CK1E |
0.752 | -0.006 | -3 | 0.579 |
MARK2 |
0.751 | -0.085 | 4 | 0.733 |
CAMK1D |
0.751 | -0.014 | -3 | 0.617 |
TTBK1 |
0.751 | -0.129 | 2 | 0.623 |
PKCE |
0.751 | 0.022 | 2 | 0.710 |
MARK3 |
0.750 | -0.079 | 4 | 0.769 |
CK1D |
0.750 | 0.018 | -3 | 0.528 |
CK1A2 |
0.750 | 0.015 | -3 | 0.529 |
BUB1 |
0.750 | 0.038 | -5 | 0.773 |
TAO2 |
0.750 | -0.082 | 2 | 0.838 |
PLK2 |
0.749 | 0.019 | -3 | 0.835 |
BRSK2 |
0.749 | -0.126 | -3 | 0.726 |
SSTK |
0.749 | -0.053 | 4 | 0.788 |
SNRK |
0.748 | -0.157 | 2 | 0.672 |
CK2A2 |
0.748 | -0.020 | 1 | 0.162 |
PKN1 |
0.748 | -0.026 | -3 | 0.647 |
PKG1 |
0.747 | 0.074 | -2 | 0.769 |
MARK1 |
0.747 | -0.105 | 4 | 0.789 |
LOK |
0.747 | -0.051 | -2 | 0.790 |
LKB1 |
0.747 | -0.075 | -3 | 0.747 |
NEK8 |
0.747 | -0.143 | 2 | 0.805 |
GRK3 |
0.747 | -0.064 | -2 | 0.587 |
CHK2 |
0.746 | -0.012 | -3 | 0.574 |
CAMKK1 |
0.746 | -0.171 | -2 | 0.741 |
NEK11 |
0.746 | -0.167 | 1 | 0.265 |
IRAK1 |
0.746 | -0.185 | -1 | 0.788 |
TAK1 |
0.744 | -0.142 | 1 | 0.238 |
PBK |
0.743 | -0.029 | 1 | 0.296 |
ROCK1 |
0.743 | 0.070 | -3 | 0.676 |
CAMKK2 |
0.743 | -0.149 | -2 | 0.759 |
CRIK |
0.743 | 0.053 | -3 | 0.632 |
SLK |
0.743 | -0.060 | -2 | 0.718 |
GCK |
0.743 | -0.116 | 1 | 0.261 |
NEK4 |
0.742 | -0.172 | 1 | 0.248 |
HPK1 |
0.742 | -0.089 | 1 | 0.259 |
CK1G1 |
0.742 | -0.038 | -3 | 0.561 |
LRRK2 |
0.741 | -0.062 | 2 | 0.837 |
TNIK |
0.741 | -0.084 | 3 | 0.804 |
CK2A1 |
0.741 | -0.024 | 1 | 0.149 |
MINK |
0.740 | -0.148 | 1 | 0.241 |
HGK |
0.740 | -0.126 | 3 | 0.802 |
CAMK1A |
0.740 | -0.006 | -3 | 0.585 |
MEKK6 |
0.739 | -0.145 | 1 | 0.257 |
MAP3K15 |
0.739 | -0.148 | 1 | 0.246 |
MST2 |
0.739 | -0.164 | 1 | 0.246 |
RIPK2 |
0.738 | -0.181 | 1 | 0.214 |
BIKE |
0.738 | -0.011 | 1 | 0.307 |
NEK1 |
0.738 | -0.172 | 1 | 0.240 |
MEK2 |
0.736 | -0.161 | 2 | 0.830 |
KHS2 |
0.736 | -0.056 | 1 | 0.269 |
VRK1 |
0.735 | -0.189 | 2 | 0.831 |
KHS1 |
0.735 | -0.093 | 1 | 0.256 |
STK33 |
0.733 | -0.115 | 2 | 0.618 |
YSK1 |
0.732 | -0.136 | 2 | 0.798 |
EEF2K |
0.732 | -0.138 | 3 | 0.763 |
MST1 |
0.731 | -0.175 | 1 | 0.236 |
TTK |
0.731 | -0.052 | -2 | 0.763 |
AAK1 |
0.730 | 0.014 | 1 | 0.305 |
NEK3 |
0.729 | -0.140 | 1 | 0.260 |
PDHK3_TYR |
0.726 | 0.146 | 4 | 0.920 |
OSR1 |
0.725 | -0.090 | 2 | 0.820 |
TAO1 |
0.724 | -0.101 | 1 | 0.241 |
ALPHAK3 |
0.724 | -0.053 | -1 | 0.728 |
ASK1 |
0.723 | -0.142 | 1 | 0.240 |
MYO3B |
0.720 | -0.101 | 2 | 0.813 |
YANK3 |
0.718 | -0.039 | 2 | 0.405 |
MYO3A |
0.717 | -0.118 | 1 | 0.259 |
PDHK4_TYR |
0.717 | 0.060 | 2 | 0.886 |
TESK1_TYR |
0.716 | 0.014 | 3 | 0.839 |
LIMK2_TYR |
0.716 | 0.095 | -3 | 0.792 |
PKMYT1_TYR |
0.715 | 0.065 | 3 | 0.840 |
MAP2K4_TYR |
0.712 | -0.034 | -1 | 0.802 |
BMPR2_TYR |
0.712 | 0.022 | -1 | 0.809 |
MAP2K7_TYR |
0.712 | -0.066 | 2 | 0.855 |
RET |
0.712 | -0.063 | 1 | 0.270 |
MAP2K6_TYR |
0.711 | 0.004 | -1 | 0.796 |
PDHK1_TYR |
0.711 | -0.035 | -1 | 0.829 |
YES1 |
0.710 | 0.006 | -1 | 0.869 |
PINK1_TYR |
0.710 | -0.084 | 1 | 0.293 |
TXK |
0.709 | -0.002 | 1 | 0.221 |
MST1R |
0.708 | -0.059 | 3 | 0.834 |
EPHA6 |
0.708 | -0.052 | -1 | 0.838 |
STLK3 |
0.707 | -0.178 | 1 | 0.220 |
CSF1R |
0.707 | -0.043 | 3 | 0.817 |
EPHB4 |
0.706 | -0.070 | -1 | 0.821 |
ABL2 |
0.706 | -0.047 | -1 | 0.830 |
TNK2 |
0.705 | -0.032 | 3 | 0.821 |
CK1A |
0.704 | -0.033 | -3 | 0.448 |
JAK2 |
0.704 | -0.111 | 1 | 0.280 |
LIMK1_TYR |
0.704 | -0.034 | 2 | 0.847 |
BLK |
0.703 | -0.002 | -1 | 0.864 |
ABL1 |
0.703 | -0.052 | -1 | 0.833 |
LCK |
0.703 | -0.030 | -1 | 0.854 |
FGFR2 |
0.702 | 0.002 | 3 | 0.814 |
SRMS |
0.702 | -0.077 | 1 | 0.219 |
TYRO3 |
0.701 | -0.122 | 3 | 0.804 |
TYK2 |
0.700 | -0.203 | 1 | 0.259 |
HCK |
0.700 | -0.077 | -1 | 0.855 |
DDR1 |
0.700 | -0.094 | 4 | 0.824 |
FYN |
0.699 | 0.001 | -1 | 0.841 |
NEK10_TYR |
0.699 | -0.101 | 1 | 0.230 |
TEC |
0.699 | -0.035 | -1 | 0.826 |
KIT |
0.699 | -0.067 | 3 | 0.818 |
EPHB1 |
0.699 | -0.098 | 1 | 0.219 |
TNK1 |
0.699 | -0.027 | 3 | 0.788 |
EPHA4 |
0.698 | -0.054 | 2 | 0.775 |
KDR |
0.698 | -0.044 | 3 | 0.799 |
TEK |
0.698 | 0.005 | 3 | 0.768 |
FGFR1 |
0.698 | -0.020 | 3 | 0.804 |
ROS1 |
0.698 | -0.145 | 3 | 0.783 |
INSRR |
0.697 | -0.088 | 3 | 0.770 |
JAK1 |
0.697 | -0.089 | 1 | 0.246 |
JAK3 |
0.696 | -0.122 | 1 | 0.248 |
EPHB2 |
0.696 | -0.086 | -1 | 0.809 |
MERTK |
0.696 | -0.081 | 3 | 0.804 |
FER |
0.696 | -0.139 | 1 | 0.249 |
AXL |
0.695 | -0.097 | 3 | 0.808 |
CK1G3 |
0.695 | -0.022 | -3 | 0.405 |
EPHA7 |
0.695 | -0.058 | 2 | 0.777 |
DDR2 |
0.695 | 0.009 | 3 | 0.782 |
FGR |
0.695 | -0.151 | 1 | 0.250 |
ITK |
0.695 | -0.107 | -1 | 0.833 |
BMX |
0.695 | -0.068 | -1 | 0.778 |
MET |
0.695 | -0.060 | 3 | 0.822 |
FLT3 |
0.694 | -0.123 | 3 | 0.808 |
PDGFRB |
0.694 | -0.149 | 3 | 0.821 |
EPHB3 |
0.694 | -0.118 | -1 | 0.819 |
FGFR3 |
0.693 | -0.018 | 3 | 0.797 |
BTK |
0.692 | -0.129 | -1 | 0.823 |
EPHA1 |
0.691 | -0.076 | 3 | 0.810 |
LTK |
0.691 | -0.092 | 3 | 0.790 |
PTK2B |
0.691 | -0.032 | -1 | 0.838 |
LYN |
0.690 | -0.054 | 3 | 0.754 |
SRC |
0.690 | -0.031 | -1 | 0.854 |
ALK |
0.689 | -0.100 | 3 | 0.769 |
EPHA8 |
0.688 | -0.046 | -1 | 0.823 |
FRK |
0.688 | -0.087 | -1 | 0.867 |
WEE1_TYR |
0.687 | -0.085 | -1 | 0.754 |
PDGFRA |
0.687 | -0.178 | 3 | 0.822 |
ERBB2 |
0.687 | -0.119 | 1 | 0.228 |
FGFR4 |
0.687 | -0.041 | -1 | 0.752 |
FLT1 |
0.686 | -0.106 | -1 | 0.782 |
EGFR |
0.686 | -0.067 | 1 | 0.191 |
EPHA3 |
0.685 | -0.106 | 2 | 0.744 |
NTRK1 |
0.685 | -0.164 | -1 | 0.774 |
PTK6 |
0.685 | -0.152 | -1 | 0.772 |
TNNI3K_TYR |
0.684 | -0.113 | 1 | 0.294 |
EPHA5 |
0.684 | -0.083 | 2 | 0.765 |
FLT4 |
0.684 | -0.120 | 3 | 0.779 |
MATK |
0.683 | -0.062 | -1 | 0.755 |
NTRK2 |
0.683 | -0.161 | 3 | 0.793 |
YANK2 |
0.682 | -0.071 | 2 | 0.428 |
CSK |
0.682 | -0.083 | 2 | 0.777 |
NTRK3 |
0.680 | -0.132 | -1 | 0.726 |
INSR |
0.680 | -0.143 | 3 | 0.747 |
PTK2 |
0.679 | -0.030 | -1 | 0.747 |
ERBB4 |
0.677 | -0.052 | 1 | 0.192 |
EPHA2 |
0.676 | -0.078 | -1 | 0.772 |
SYK |
0.674 | -0.059 | -1 | 0.733 |
CK1G2 |
0.669 | -0.049 | -3 | 0.489 |
MUSK |
0.668 | -0.144 | 1 | 0.176 |
IGF1R |
0.666 | -0.124 | 3 | 0.698 |
FES |
0.665 | -0.084 | -1 | 0.762 |
ZAP70 |
0.654 | -0.064 | -1 | 0.664 |